N (2015-2019)

STUDIES ON CONDITIONS and RELATED ARTICLES 2015-2019

*Articles/Studies in Pre-2000 List
+Articles/Studies in 2000-2009 List
^Articles/Studies in 2010-2014 List
>Information in Another Section

>NAIL-PATELLA SYNDROME+ (See also News Articles 2010-2018)
NARCOLEPSY
NAUSEA*+ (See Also MORNING SICKNESS, MOTION SICKNESS, RADIATION-INDUCED NAUSEA)
NEOINTIMA (Thickening of Arterial Walls)
NEUROGENESIS (Formation of New Neurons)
NEUROMA (Growth or Tumor on Nerve Tissue – Tend to be Benign (Non-Cancerous)
NEUROMYELITIS OPTICA/DEVICA’S DISEASE~ (Disorder Causing Swelling of Eye Nerves)
NEURONS/BRAIN CELLS*+
NEUROPATHIC PAIN*+
NEUROPROTECTION*+
>NIEMANN-PICK DISEASE (Neurodegenerative Lysosomal Storage Disorder. See Also Pre-2000 List)
NIGHTMARES/DREAMS
NIGHT SWEATS (See also 2000-2009 section)
NOSE/NASAL PROBLEMS (See Also SMELL/ODOR DETECTION)
NUTRITION-GENERAL*+ (See Also OMEGA-3/CB1 CONNECTION, METHODS OF USE-EDIBLES)
NUTRITION-HEMP SEED*+
NUTRITION-HEMP SEED OIL*+ (See Also OMEGA-3/CB1 CONNECTION)
NUTRITION-HEMP SEED PROTEIN ISOLATES/POWDERS
NUTRITION-HIGH FAT DIET and the ENDOCANNABINOID SYSTEM


NAIL-PATELLA SYNDROME+
Dermatology-Related Uses of Medical Cannabis Promoted by Dispensaries in Canada,
Europe, and the United States 
(abst–2018)  http://journals.sagepub.com/doi/abs/10.1177/1203475418808761?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=cmsa


NARCOLEPSY 
Emerging Drugs for Common Conditions of Sleepiness: Obstructive Sleep Apnea and
Narcolepsy (full–2015)  http://www.tandfonline.com/doi/full/10.1517/14728214.2015.1115480


NAUSEA*+
The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility (full–2015) http://www.casereports.com/article/S2210-2612%2815%2900219-9/pdf
Cannabis in cancer care (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.108/full
top

Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemetic (full–2015) http://www.ccjm.org/index.php?id=107953&tx_ttnews%5Btt_news%5D=412809&cHash=0c1f8670f2fa499ee88aeff79ee2a47e
Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251&resultClick=24
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015)
http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Novel associations between FAAH genetic variants and postoperative central opioid related adverse effects (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492912/
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy  (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009464.pub2/full
Medical marijuana: Hints of headway? Despite a conflicted regulatory landscape, support for medical marijuana is growing amid increasing evidence of potential benefits (Part 2 of 2) (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21524/full
Medical Marijuana: Is the Cart Before the Horse? (1st page–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338230
Intra-visceral insular cortex 2-arachidonoylglycerol, but not N-arachidonoylethanolamide, suppresses acute nausea-induced conditioned gaping in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25499318
The role of cannabinoids in regulation of nausea and vomiting, and visceral pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715910
Cannabinoids suppress acute and anticipatory nausea in pre-clinical rat models of conditioned gaping (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25691302
Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26030435
Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26297326
Cannabis – therapy for the future? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26375695
Effect of combined doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26381155
top
Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26439367
Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815301623
Controlled release tablet formulation containing natural δ9 tetrahydrocannabinol (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098422/
Endocannabinoid Mechanisms Influencing Nausea (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638766
Intravenous Delta-9-Tetrahydrocannabinol to Prevent Postoperative Nausea and Vomiting: A Randomized Controlled Trial (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26426861
Cannabis and cancer: toward a new understanding (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791146/
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869612/
The Gut-Itch Connection (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/exd.12994/full
The involvement of TRPV1 in emesis and anti-emesis (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843889/
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
The role of the endocannabinoid system in the brain-gut axis (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961581/
Hypophosphatemia in Users of Cannabis (full–2016) http://www.ajkd.org/article/S0272-6386(16)30414-0/fulltext
Elevation of 2-AG by monoacylglycerol lipase inhibition in the visceral insular cortex  interferes with anticipatory nausea in a rat model (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793281/
Variants in the CNR1 gene predispose to headache with nausea in the presence of life  stress (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347942/
A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol  lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory
nausea in rat models (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531749/
Using Medical Cannabis in an Oncology Practice (article–2016)  http://www.cancernetwork.com/oncology-journal/using-medical-cannabis-oncology-practice#sthash.CjT8fR9n.uWvEhfSG.dpuf
Cannabis and Cannabinoids (1st page–2016)  http://jamanetwork.com/journals/jama/article-abstract/2592497
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26767992
Adverse effects after the use of JWH-210 – a case series from the EU Spice II plus project  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26768345
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review (abst in German & English-2016)  https://link.springer.com/article/10.1007%2Fs00482-015-0087-0
Cannabinoid 2 (CB2) receptor agonism reduces lithium chloride-induced vomiting in Suncus murinus and nausea-induced conditioned gaping in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27263826
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27407130
Effect of combined oral doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27438607
Novel Treatments for Cyclic Vomiting Syndrome: Beyond Ondansetron and Amitriptyline (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757817
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65875/
Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65755/
Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use (full–2017)  http://onlinelibrary.wiley.com/doi/10.1002/cncr.30879/full
Overview of Chemotherapy-Induced Nausea and Vomiting and Evidence-Based  Therapies (full–2017) http://www.ajmc.com/journals/supplement/2017/managed-care-considerations-in-chemotherapy-induced-nausea-andvomiting/overview-of-chemotherapy-induced-nausea-and-vomiting-and-evidence-based-therapies-article/
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications  (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
Systematic review of safeness and therapeutic efficacy of cannabis in patients with  multiple sclerosis, neuropathic pain, and in oncological patients treated with  chemotherapy (abst in English–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29119763  (full in Italian)  http://www.epiprev.it/articolo_scientifico/revisione-sistematica-sull%E2%80%99efficacia-terapeutica-e-la-sicurezza-della-cannabis
Role of cannabis in digestive disorders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/27792038
A randomized-controlled trial of nabilone for the prevention of acute postoperative  nausea and vomiting in elective surgery. (abst in English & French–2017)  https://link.springer.com/article/10.1007%2Fs12630-017-0814-3
Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28235999
Cannabinoid signaling in health and disease (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28263083
Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated  With Cyclic Vomiting Syndrome (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28349993
Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency  department: a case series (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/15563650.2017.1324166?journalCode=ictx20
Experts’ Perspectives on the Role of Medical Marijuana in Oncology: a semi-structured  interview study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28040884
Medical Cannabinoids in Children and Adolescents: A Systematic Review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29061872
Cannabinoids for nausea and vomiting related to chemotherapy: Overview of systematic  reviews (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29168289
Are cannabinoids effective for the management of chemotherapy induced nausea and  vomiting? (abst in English, link to abst in Spanish–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29286355
The therapeutic effects of Cannabis and cannabinoids: An update from the National  Academies of Sciences, Engineering and Medicine report (abst–2018) http://www.ejinme.com/article/S0953-6205(18)30003-7/fulltext

Cannabinoid pharmacology and therapy in gut disorders (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303186

Conditioned gaping produced by high dose Δ9-tetrahydracannabinol: Dysregulation of the hypothalamic endocannabinoid system (abst–2018) https://www.sciencedirect.com/science/article/pii/S0028390818305987?via%3Dihub

Medical Cannabis Use by Hodgkin Lymphoma Patients: Experience of a Single Center (abst–2018) https://www.karger.com/Article/Abstract/493567

Medicinal cannabis for chemotherapy-induced nausea and vomiting: prescribing with limited evidence (abst–2018) https://www.mja.com.au/journal/2018/210/1/medicinal-cannabis-chemotherapy-induced-nausea-and-vomiting-prescribing-limited

Recent Trends in Cyclic Vomiting Syndrome – Associated Hospitalizations with Liberalization of Cannabis Use in the State of Colorado (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30426628

Impact of recreational and medicinal marijuana on surgical patients: A review (abst–2018) https://www.americanjournalofsurgery.com/article/S0002-9610(18)31123-1/fulltext

Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal (abst–2018) https://www.msard-journal.com/article/S2211-0348(18)30515-7/fulltextMedical Marijuana in Cancer Treatment: No Standards of Care, and So Far, No Coverage (abst–2018) https://www.ajmc.com/journals/evidence-based-oncology/2018/october-2018/medical-marijuana-in-cancer-treatment-no-standards-ofcare-and-so-far-no-coverage

2019 Cannabis and Cannabinoids (PDQ®) Patient Version (full–2019) https://www.ncbi.nlm.nih.gov/books/NBK65875/

Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345719/

Medical Cannabis Certification in a Large Pediatric Oncology Center (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617193/

Relationship of Cannabis Use to Patient-Reported Symptoms in Cancer Patients Seeking Supportive/Palliative Care (full–2019) https://www.liebertpub.com/doi/full/10.1089/jpm.2018.0533?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed

Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study (full–2019) https://www.cambridge.org/core/journals/palliative-and-supportive-care/article/cannabis-treatment-in-hospitalized-patients-using-thesyqe-inhaler-results-of-a-pilot-openlabel-study/0C1940413E704A7EADCB949F5F49603A/core-reader

Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome (full–2019) https://onlinelibrary.wiley.com/doi/full/10.1111/nmo.13606

The use of cannabis in supportive care and treatment of brain tumor (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655483/

Should Oncologists Recommend Cannabis? (article–2019)  https://link.springer.com/article/10.1007%2Fs11864-019-0659-9

Progress in cannabis research from a pharmaceutical chemist’s point of view (Germany) (abst in English & German–2019) https://link.springer.com/article/10.1007%2Fs00103-019-02964-4

Efficacy and safety of medicinal cannabis: results of the CaPRis study. (Germany) (abst in English & German–2019) https://link.springer.com/article/10.1007%2Fs00103-019-02965-3

Cannabis for cancer – illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30572744

Cannabis and Turmeric as Complementary Treatments for IBD and Other Digestive Diseases (abst–2019) https://link.springer.com/article/10.1007%2Fs11894-019-0670-0

Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009–2016 (abst–2019) https://www.sciencedirect.com/science/article/pii/S0376871619300080?via%3Dihub

Cannabis Oil Use by Adolescents and Young Adults With Inflammatory Bowel Disease (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30801394
Impact of Medical Cannabis on Patient-Reported Symptoms for Patients With Cancer Enrolled in Minnesota’s Medical Cannabis Program (abst–2019) https://ascopubs.org/doi/abs/10.1200/JOP.18.00562?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=jop

Patient Counseling Guidelines for the Use of Cannabis for the Treatment of Chemotherapy-Induced Nausea/Vomiting and Chronic Pain (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31070496

Patterns of Cannabis Use In Patients With Cyclic Vomiting Syndrome (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31352091

Opportunities for cannabis in supportive care in cancer (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31413731


NEOINTIMA
Abstract 577: Medical Marijuana Use: Effect on Lipid Metabolism and Atherosclerosis  (abst–2015) http://atvb.ahajournals.org/content/35/Suppl_1/A577
top


NEUROGENESIS+
Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/hipo.22344/full
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s Disease (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567222/
Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00379/full
The role of cannabinoids in adult neurogenesis (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543605/
CB1 cannabinoid receptor enrichment in the ependymal region of the adult human spinal cord (full–2015) http://www.nature.com/articles/srep17745
Ultra-low doses of tetrahydrocannabinol contribute to the survival of newly-born cells in the dentate gyrus of adult rats (2 pages–2015)  http://link.springer.com/article/10.1134/S1819712415030046
Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S027858461530004X
ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26225920
Dual effects of the non-esterified fatty acid receptor ‘GPR40’ for human health (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25615413
Cannabinoid receptor signaling induces proliferation but not neurogenesis in the mouse  olfactory epithelium (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973592/
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke (full–2016) http://stroke.ahajournals.org/content/48/1/204.long
Cannabidiol, neuroprotection and neuropsychiatric disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816000396 Immunohistochemical distribution of the cannabinoid receptor 1 and fatty acid amide hydrolase in the dog claustrum (abst–2016) http://www.sciencedirect.com/science/article/pii/S0891061815300405
Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27027565
Distinctive effects of eicosapentaenoic and docosahexaenoic acids in regulating neural stem cell fate are mediated via endocannabinoid signalling pathways (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301277
Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and
endocannabinoids (abst–2016) 
http://www.sciencedirect.com/science/article/pii/S0018506X16301799
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524

Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27918106
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer’s Disease  (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00020/full
A Long-Term Treatment with Arachidonyl-2′-Chloroethylamide Combined with Valproate Increases Neurogenesis in a Mouse Pilocarpine Model of Epilepsy (full–2017) http://www.mdpi.com/1422-0067/18/5/900
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of  Cannabidiol in Psychiatric Disorders (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00269/full
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid (full–2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
Interaction between Cannabinoid Type 1 and Type 2 Receptors in the Modulation of  Subventricular Zone and Dentate Gyrus Neurogenesis (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00516/full
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and  Relevant Animal Studies (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
Interplay Between n-3 and n-6 Long-Chain Polyunsaturated Fatty Acids and the  Endocannabinoid System in Brain Protection and Repair (full–2017)  https://link.springer.com/article/10.1007%2Fs11745-017-4292-8
AM1241 alleviates MPTP-induced Parkinson’s disease and promotes the regeneration of  DA neurons in PD mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620217/
Cannabinoid Modulation of the Stressed Hippocampus (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742214/
HDAC1 and HDAC3 Underlie Dynamic H3K9 Acetylation During Embryonic  Neurogenesis and in Schizophrenia-like Animals (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28300292
AM1241 alleviates MPTP-induced Parkinson’s disease and promotes the regeneration of  DA neurons in PD mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620217/
Maternal Cannabinoid Use Alters Cannabinoid (CB1) and Endothelin (ETB) Receptor
Expression in the Brains of Dams but Not Their Offspring (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/29131068
Acute ethanol inhibition of adult hippocampal neurogenesis involves CB1 cannabinoid receptor signaling (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29417597
The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling (abst-2018) https://www.sciencedirect.com/science/article/pii/S0028390818301023?via%3Dihub
Biphasic Effects of THC in Memory and Cognition (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29574698
N-Docosahexaenoylethanolamine: A neurotrophic and neuroprotective metabolite of
docosahexaenoic acid (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0098299718300244
Mechanisms underlying the effects of n-3 polyunsaturated fatty acids on fear memory processing and their hypothetical effects on fear of cancer recurrence in cancer survivors (abst–2018) https://www.plefa.com/article/S0952-3278(17)30303-4/fulltext
Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29797438
Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesis (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29888782
Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors
Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic
Pain (abst–2018) 
https://www.ncbi.nlm.nih.gov/pubmed/29863609
Modulation of the Cannabinoid System: A New Perspective for the Treatment of the
Alzheimer’s Disease (abst–2018) 
https://www.ncbi.nlm.nih.gov/pubmed/29962346

Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus (abst–2018) https://www.sciencedirect.com/science/article/pii/S0028390818307135?via%3Dihub

Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms (abst–2019) https://www.sciencedirect.com/science/article/pii/S0891061818302114?via%3Dihub


NEUROMA
Mechanisms and treatment of painful neuromas (full–2018)  https://www.degruyter.com/view/j/revneuro.ahead-of-print/revneuro-2017-0077/revneuro-2017-0077.xml

top


NEURONS/BRAIN CELLS*+
Augmented Inhibition from Cannabinoid-Sensitive Interneurons Diminishes CA1 Output after Traumatic Brain Injury (full–2015) http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00435/full
top
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/glia.22742/full
Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/adb.12080/full
Cannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A review (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/25685481
Genetic Dissection of Behavioural and Autonomic Effects of Δ9-Tetrahydrocannabinol in Mice (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.0050269
The Combined Inhibitory Effect of the Adenosine A1 and Cannabinoid CB1 Receptors on cAMP Accumulation in the Hippocampus Is Additive and Independent of A1 Receptor Desensitization (full–2015) http://www.hindawi.com/journals/bmri/2015/872684/
Drugs of Abuse in HIV infection and neurotoxicity (full–2015) http://journal.frontiersin.org/article/10.3389/fmicb.2015.00217/full
WIN 55,212-2, Agonist of Cannabinoid Receptors, Prevents Amyloid β1-42 Effects on Astrocytes in Primary Culture (full–2015) http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0122843&representation=PDF
Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS (full–2015) http://www.hindawi.com/journals/bmri/2015/980983/
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection (full–2015) http://www.molecularneurodegeneration.com/content/pdf/s13024-015-0012-0.pdf
Role for Endogenous BDNF in Endocannabinoid-Mediated Long-Term Depression at Neocortical Inhibitory Synapses (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415885/
Sex-dependent vulnerability to Cannabis abuse in adolescence (full–2015) http://journal.frontiersin.org/article/10.3389/fpsyt.2015.00056/full
Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice (full–2015) http://www.nature.com/srep/2015/150330/srep09490/full/srep09490.html
Effects of high-fructose diets on central appetite signaling and cognitive function (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429636/
Rapid Non-Genomic Glucocorticoid Actions in Male Mouse Hypothalamic Neuroendocrine Cells Are Dependent on the Nuclear Glucocorticoid Receptor (full–2015) http://press.endocrine.org/doi/pdf/10.1210/en.2015-1273
The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K / Akt / mTORC1 / BDNF pathway (full–2015) http://www.nature.com/cdd/journal/vaop/ncurrent/full/cdd201511a.html
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0129618
Palmitoylethanolamide Inhibits Glutamate Release in Rat Cerebrocortical Nerve Terminals (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394492/
Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals (full–2015) http://www.nature.com/ncomms/2015/150420/ncomms7557/full/ncomms7557.html
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures (full–2015) http://www.hindawi.com/journals/np/2015/130639/
Lack of hypophagia in CB1 null mice is associated to decreased hypothalamic POMC and CART expression (full–2015)  http://ijnp.oxfordjournals.org/content/early/2015/03/09/ijnp.pyv011.long
Homeostatic regulation of brain functions by endocannabinoid signaling (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468750/
Metabolic Interplay between Astrocytes and Neurons Regulates Endocannabinoid  Action (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2900725-1
Impaired 2-AG signaling in hippocampal glutamatergic neurons: aggravation of anxiety like behavior and unaltered seizure susceptibility (full–2015) http://ijnp.oxfordjournals.org/content/ijnp/early/2015/07/29/ijnp.pyv091.full.pdf
Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release (full–2015) http://www.jneurosci.org/content/35/27/10039.full?sid=7e769d1b-9b77-42fe-92d0-8b337b34b9b6
Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments (full–2015) http://www.nature.com/articles/srep15453
Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00379/full
The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002286
Increased Cortical Inhibition in Autism-Linked Neuroligin-3R451C Mice Is Due in Part to Loss of Endocannabinoid Signaling (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140638
Coordinated Regulation of Synaptic Plasticity at Striatopallidal and Striatonigral Neurons Orchestrates Motor Control (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2901163-8
Fine-tuning of synaptic upscaling at excitatory synapses by endocannabinoid signaling is mediated via the CB1 receptor (full–2015) http://www.nature.com/articles/srep16257
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling (full–2015) http://www.mdpi.com/2076-3425/5/4/456/htm
Endocannabinoid signaling mediates oxytocin-driven social reward (full–2015) http://www.pnas.org/content/112/45/14084.full
Ventral tegmental area dopamine and GABA neurons: Physiological properties and expression of mRNA for endocannabinoid biosynthetic elements (full–2015) http://www.nature.com/articles/srep16176
Loss of Either Rac1 or Rac3 GTPase Differentially Affects the Behavior of Mutant Mice and the Development of Functional GABAergic Networks (full–2015) http://cercor.oxfordjournals.org/content/early/2015/11/17/cercor.bhv274.long
Hypothalamic control of brown adipose tissue thermogenesis (full–2015) http://journal.frontiersin.org/article/10.3389/fnsys.2015.00150/full
CB1 cannabinoid receptor enrichment in the ependymal region of the adult human spinal cord (full–2015) http://www.nature.com/articles/srep17745
Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00457/full
Cannabinoid receptor activation in the juvenile rat brain results in rapid biomechanical alterations: Neurovascular mechanism as a putative confounding factor (full–2015) http://jcb.sagepub.com/content/early/2015/09/23/0271678X15606923.long
top
cnrip1 is a regulator of eye and neural development in Xenopus laevis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/gtc.12225/full
To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681836/
Neural correlates of cannabidiol and Δ9-tetrahydrocannabinol interactions in mice: implications for medical cannabis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13333/full
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease (full–2015) http://www.sciencedirect.com/science/article/pii/S0014488615300583
Deletion of Monoglyceride Lipase in Astrocytes Attenuates Lipopolysaccharide-Induced Neuroinflammation (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705409/
Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2900926-2
Cellular Mechanisms of Action of Drug Abuse on Olfactory Neurons (full–2015) http://www.mdpi.com/1660-4601/13/1/5/htm
Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons (full–2015) http://www.alcoholjournal.org/article/S0741-8329%2815%2930019-7/fulltext
Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348185/
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516969/
VGluT3-Expressing CCK-Positive Basket Cells Construct Invaginating Synapses  Enriched with Endocannabinoid Signaling Proteins in Particular Cortical and Cortex-Like Amygdaloid Regions of Mouse Brains (full–2015) http://www.jneurosci.org/content/35/10/4215.long
Cannabinoid CB1 Receptor Calibrates Excitatory Synaptic Balance in the Mouse Hippocampus (full–2015) http://www.jneurosci.org/content/35/9/3842.long
Role of dopamine type 1 receptors and DARPP-32 in Δ9-THC-mediated induction of ΔFosB in the mouse forebrain (full–2015) http://jpet.aspetjournals.org/content/early/2015/06/22/jpet.115.224428.long
Neurotoxicity of Synthetic Cannabinoids JWH-081 and JWH-210 (full–2015) http://www.biomolther.org/journal/view.html?volume=23&number=6&spage=597&year=2015
Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol (MAGL) does not cause neurodegeneration in neonatal mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490952/
Enhancement of endocannabinoid signalling protects against cocaine-induced neurotoxicity (full–2015) http://www.sciencedirect.com/science/article/pii/S0041008X15001556
Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13215/full
Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 (CB1 ) receptors located on glutamatergic neurons and on astrocytes (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jnc.13044/full
Simultaneous inhibition of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) shares discriminative stimulus effects with ∆9-THC in mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407717/
Peroxide-Dependent MGL Sulfenylation Regulates 2-AG-Mediated Endocannabinoid Signaling in Brain Neurons (full–2015) http://www.sciencedirect.com/science/article/pii/S107455211500157X
A highly selective, reversible inhibitor identified by comparative chemoproteomics modulates diacylglycerol lipase activity in neurons (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773911/
Anandamide Depresses Glycinergic and GABAergic Inhibitory Transmissions in Adult Rat Substantia Gelatinosa Neurons (full–2015) http://file.scirp.org/Html/1-2500613_54452.htm
Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332989/
Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation (full–2015) http://molpharm.aspetjournals.org/content/87/4/747.long
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604192/
Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917208/
The role of cannabinoids in adult neurogenesis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543605/
Differential Pharmacological Regulation of Sensorimotor-Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569956/
An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485596/
Ultrastructural evidence for synaptic contacts between cortical noradrenergic afferents and endocannabinoid-synthesizing post-synaptic neurons (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542008/
Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jnc.13288/full
Habenular CB1 Receptors Control the Expression of Aversive Memories (full – 2015) http://www.cell.com/neuron/fulltext/S0896-6273(15)00729-1
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling (full–2015) http://www.cell.com/cell/fulltext/S0092-8674(15)00826-0
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism (full–2015) http://link.springer.com/article/10.1007/s00429-014-0823-8
top
Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment  (full–2015) https://academic.oup.com/abbs/article-lookup/doi/10.1093/abbs/gmv049
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552583/
Active endocannabinoids are secreted on extracellular membrane vesicles (full–2015) http://embor.embopress.org/content/early/2015/01/07/embr.201439668
Phenotype-dependent inhibition of glutamatergic transmission on nucleus accumbens medium spiny neurons by the abused inhalant toluene (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561223/
Maternal separation and early stress cause long-lasting effects on dopaminergic and  endocannabinergic systems and alters dendritic morphology in the nucleus accumbens and frontal cortex in rats (full–2015)  http://onlinelibrary.wiley.com/doi/10.1002/dneu.22361/full
Negative Regulation of Leptin-induced ROS Formation by CB1 Receptor Activation in  Hypothalamic Neurons (link to PDF–2015)  http://www.jbc.org/content/early/2015/04/13/jbc.M115.646885.full.pdf+html
Cannabinoid Receptors May Control Aversive Memories (news & abstract-2015)  http://neurosciencenews.com/habenula-cb1-receptors-memory-2742/
Oxytocin Enhances Pleasure of Social Interactions by Stimulating Production of “Bliss  Molecule” (news & abstract–2015) http://neurosciencenews.com/oxytocin-anandamide-2926/
The basolateral amygdala γ-aminobutyric acidergic system in health and disease  (abst–2015) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23690/full
Dissecting the cannabinergic control of behavior: The where matters (abst–2015) http://onlinelibrary.wiley.com/doi/10.1002/bies.201500046/abstract;jsessionid=222EC084D6C5E7ECF95BFF9D2752CFE4.f01t01
Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on  Mesocorticolimbic Dopamine Function (abst–2015)  https://www.ncbi.nlm.nih.gov/pubmed/26638769
On the Role of Astroglial Syncytia in Self-Repairing Spiking Neural Networks (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25576582
Cannabinoid agonists rearrange synaptic vesicles at excitatory synapses and depress motoneuron activity in vivo (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595101
Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25819934
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst–2015) http://www.sciencedirect.com/science/article/pii/S0024320515000521
A Synthetic Cannabinoid MAM-2201 Potently Suppresses Synaptic Transmission via
Activation of Presynaptic CB1 Receptors and Reduces Synaptically-Evoked Intracellular Ca2+ Transients in Cerebellar Purkinje Cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25747605
Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25788026
Further Evidence for the Neuroplastic Role of Cannabinoids: A Study in Organotypic Hippocampal Slice Cultures (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25645684
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25795598
Individual differences and vulnerability to drug addiction: a focus on the  endocannabinoid system (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25714966
Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25813826
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25814137
Localization and production of peptide endocannabinoids in the rodent CNS and adrenal medulla (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25839900
The interactive role of cannabinoid and vanilloid systems in hippocampal synaptic plasticity in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25843413
top
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-endoccannabinoid receptor in the ventral mesencephalon (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25841876
Emerging concepts of pain therapy based on neuronal mechanisms (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25846611
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863279
Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25910421
Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats (abst–2015) http://www.sciencedirect.com/science/article/pii/S0024320515002155
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
Astroglial type-1 cannabinoid receptors (CB1): A new player in the tripartite synapse (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25967266
Layer-specific endocannabinoid-mediated LTD of GABAergic neurotransmission onto principal neurons in mouse visual cortex (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25997857
Signaling Mechanism of Cannabinoid Receptor-2 Activation-Induced β-Endorphin Release (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26108183
Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26115586
Endocannabinoid signaling mechanisms in the substantia nigra pars reticulata modulate GABAergic nigrotectal pathways in mice threatened by urutu-cruzeiro venomous pit viper snake (abst–2015) http://www.sciencedirect.com/science/article/pii/S0306452215005898
Effect of Homocysteine on Voltage-Gated Sodium Channel Currents in Primary Cultured Rat Caudate Nucleus Neurons and Its Modulation by 2-Arachidonylglycerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179279
Comparative effects of parathion and chlorpyrifos on endocannabinoid and endocannabinoid-like lipid metabolites in rat striatum (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26215119
ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26225920
Neuroprotective mechanisms of cannabinoids in brain ischemia and neurodegenerative disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26299059
Pro-inflammatory obesity in aged cannabinoid-2 receptor deficient mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26303348
Genetic Manipulation of the Endocannabinoid System (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408160
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411568
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408049
Intracellular postsynaptic cannabinoid receptors link thyrotropin-releasing hormone receptors to TRPC-like channels in thalamic paraventricular nucleus neurons (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26470810
Excitatory drive from the subthalamic nucleus attenuates GABAergic transmission in the Substantia Nigra pars compacta via endocannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26472124
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815301441
The brain in bone and fuel metabolism (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26545334
top
The neuroprotection of cannabidiol against MPP+-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson’s disease (abst–2015) http://www.sciencedirect.com/science/article/pii/S0887233315300047
The interactive role of CB1 and GABAB receptors in hippocampal synaptic plasticity in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26611204
The Endocannabinoid System and Its Role in Regulating the Intrinsic Neural Circuitry of the Gastrointestinal Tract (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26638765
Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26681496
Synthetic and endogenous cannabinoids protect retinal neurons from AMPA  excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and  MEK/ERK signaling pathways (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0014483515001554

Dual effects of the non-esterified fatty acid receptor ‘GPR40’ for human health (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25615413
Expression and Function of the Endocannabinoid System in the Retina and the Visual Brain (full–2016) http://www.hindawi.com/journals/np/2016/9247057/
Characterization of a novel adult murine immortalized microglial cell line and its activation by amyloid-beta (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0484-z
GABABR-Dependent Long-Term Depression at Hippocampal Synapses between CB1- Positive Interneurons and CA1 Pyramidal Cells (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00004/full
GABA and Endocannabinoids Mediate Depotentiation of Schaffer Collateral Synapses Induced by Stimulation of Temperoammonic Inputs (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0149034
top
Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease (full–2016) http://www.hindawi.com/journals/np/2016/8373020/
Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00027/full
Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses (full–2016) http://www.nature.com/mp/journal/vaop/ncurrent/full/mp201622a.html
Estrogen Receptor Beta and 2-arachidonoylglycerol Mediate the Suppressive Effects of Estradiol on Frequency of Postsynaptic Currents in Gonadotropin-Releasing Hormone Neurons of Metestrous Mice: An Acute Slice Electrophysiological Study (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00077/full
Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment (full–2016) http://journals.lww.com/tnpj/Fulltext/2016/01000/Cannabis_for_posttraumatic_stress_disorder__A.6.aspx
Synthetic Ligands of Cannabinoid Receptors Affect Dauer Formation in the Nematode Caenorhabditis elegans (full–2016) http://www.g3journal.org/content/early/2016/04/11/g3.116.026997.long
Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155759#pone.0155759.ref024
Neuronal and Astrocytic Monoacylglycerol Lipase Limit the Spread of Endocannabinoid Signaling in the Cerebellum (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865651/
Cannabinoid receptor type-1: breaking the dogmas (full–2016) http://f1000research.com/articles/5-990/v1
CB2 Cannabinoid Receptor As Potential Target against Alzheimer’s Disease (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00243/full#B36
p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907698/
Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation (full–2016) http://www.cell.com/neuron/fulltext/S0896-6273%2816%2930157-X
Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer’s disease (full–2016) http://www.sciencedirect.com/science/article/pii/S0028390816300879
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids (full–2016) http://www.nature.com/articles/npjamd201612
Enkephalin levels and the number of neuropeptide Y-containing interneurons in the hippocampus are decreased in female cannabinoid-receptor 1 knock-out mice (full–2016) http://www.sciencedirect.com/science/article/pii/S0304394016301689
Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker Rat: Role of Cannabinoid Receptors (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902197/
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10095&path%5B%5D=31745
L-type calcium channels and MAP kinase contribute to thyrotropin-releasing hormone induced depolarization in thalamic paraventricular nucleus neurons (full–2016) http://ajpregu.physiology.org/content/310/11/R1120.long
Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899471/
Effect of interaction between acute administration of morphine and cannabinoid compounds on spontaneous excitatory and inhibitory postsynaptic currents of magnocellular neurons of supraoptic nucleus (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951608/
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid mediated disinhibition of dopaminergic neurons (full–2016) http://www.nature.com/ncomms/2016/160722/ncomms12199/full/ncomms12199.html
Endocannabinoids and Heterogeneity of Glial Cells in Brain Function (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932105/
Orchestrated activation of mGluR5 and CB1 promotes neuroprotection (full–2016) http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-016-0259-6
A role of CB1R in inducing θ-rhythm coordination between the gustatory and gastrointestinal insula (full–2016) http://www.nature.com/articles/srep32529
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00415/full
fMRI study of neural sensitization to hedonic stimuli in long-term, daily cannabis users (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012952/
Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843434/
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood (full–2016) http://learnmem.cshlp.org/content/23/7/349.long
Ontogeny of sensorimotor gating and short-term memory processing throughout the adolescent period in rats (full–2016) http://www.sciencedirect.com/science/article/pii/S1878929316300639
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801305/
Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052277/
Orexin-A represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855580/
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892852/
Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868450/
Neurophysiology of space travel: energetic solar particles cause cell type-specific plasticity of neurotransmission (full–2016) http://link.springer.com/article/10.1007%2Fs00429-016-1345-3
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis (full–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16304476
Diacylglycerol lipase disinhibits VTA dopamine neurons during chronic nicotine exposure (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743781/
Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization  of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling  Pathway (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854973/
Spatial Distribution of the Cannabinoid Type 1 and Capsaicin Receptors May Contribute to the Complexity of Their Crosstalk (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032030/
Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075776/
Endocannabinoid signaling regulates regenerative axon navigation in Caenorhabditis elegans via the GPCRs NPR-19 and NPR-32 (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/gtc.12377/full
Alteration of SLP2‐like immunolabeling in mitochondria signifies early cellular damage in developing and adult mouse brain (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784115/
Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons (full–2016) http://www.sciencedirect.com/science/article/pii/S221323171630338X
Lipids in psychiatric disorders and preventive medicine (full–2016)  http://www.sciencedirect.com/science/article/pii/S0149763415303353
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders (full–2016) http://www.sciencedirect.com/science/article/pii/S0960894X16306874
Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid  Release in the Basolateral Amygdala (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978804/
Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958898/
Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase (full–2016) https://www.ncbi.nlm.nih.gov/pubmed/27806235
Dentate cannabinoid-sensitive interneurons undergo unique and selective strengthening of mutual synaptic inhibition in experimental epilepsy (full–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26804027
Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal  Long-Term Potentiation (full–2016) https://academic.oup.com/cercor/article-lookup/doi/10.1093/cercor/bhw052
Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of  memory consolidation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024630/
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome  After Stroke (full–2016) http://stroke.ahajournals.org/content/48/1/204.long
Antagonism of dopamine receptor 2 long (D2L) affects cannabinoid receptor 1 (CB1)  signaling in a cell culture model of striatal medium spiny projection neurons (full–2016) http://molpharm.aspetjournals.org/content/89/6/652.long
Differences in Chloride Gradients Allow for Three Distinct Types of Synaptic  Modulation by Endocannabinoids (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982905/
Projection-Specific Dynamic Regulation of Inhibition in Amygdala Micro-Circuits  (full–2016) http://www.cell.com/neuron/fulltext/S0896-6273(16)30346-4?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0896627316303464%3Fshowall%3Dtrue
Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by the excess microglia-mediated inflammation (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931157/
The effects of Δ9-tetrahydrocannabinol on the dopamine system (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123717/
Cannabidiol Modulates Fear Memory Formation through Interactions with Serotonergic Transmission in the Mesolimbic System (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061893/
Muscarinic acetylcholine receptors control baseline activity and Hebbian stimulus-timing dependent plasticity in fusiform cells of the dorsal cochlear nucleus (full–2016) https://www.physiology.org/doi/full/10.1152/jn.00270.2016
Role of Cannabinoid Receptor Type 1 in Tibial and Pudendal Neuromodulation of
Bladder Overactivity in Cats (full–2016) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374309/
Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220555/
Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969232/
FABP1 in wonderland (full–2016)  https://onlinelibrary.wiley.com/doi/full/10.1111/jnc.13664
PAK1 regulates inhibitory synaptic function via a novel mechanism mediated by
endocannabinoids (full–2016) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997138/
Inflammation of peripheral tissues and injury to peripheral nerves induce diferring effects in the expression of the calcium-sensitive anandamide-synthesising enzyme and related molecules in rat primary sensory neurons (link to PDF–2016)  https://spiral.imperial.ac.uk:8443/handle/10044/1/43081
Harvesting Benefits from Cannabinoids (article–2016)  http://www.cell.com/cell/fulltext/S0092-8674(16)31675-0

Suppressing Schizophrenia Symptoms Without Side Effects: Mouse Study (news & abst–2016) http://neurosciencenews.com/schizophrenia-compound-striatum-5089/
Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26739712
Major dorsoventral differences in the modulation of the local CA1 hippocampal network by NMDA, mGlu5, adenosine A2A and cannabinoid CB1 receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26762803
The endocannabinoid system and neuropathic pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26785153
Stimulation of cannabinoid CB1 receptors prevents nerve-mediated airway hyperreactivity in NGF-induced inflammation in mouse airways (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26896777
The Hyperpolarization-Activated Cation Current Ih: The Missing Link Connecting Cannabinoids to Cognition (abst–2016) http://www.cell.com/neuron/abstract/S0896-6273(16)00144-6?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0896627316001446%3Fshowall%3Dtrue
Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27027565

Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816302663
Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597 (abst–2016) http://www.sciencedirect.com/science/article/pii/S0168010216300220
Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816303449
WHERE’s MY ENTOURAGE? THE CURIOUS CASE OF 2-oleoylglycerol, 2- linolenoylglycerol, and 2-palmitoylglycerol (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816303346
Endocannabinoid 2-Arachidonoylglycerol Suppresses LPS-Induced Inhibition of A-Type Potassium Channel Currents in Caudate Nucleus Neurons Through CB1 Receptor (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27129498
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus (abst–2016) http://www.cell.com/neuron/abstract/S0896-6273%2816%2930025-3
Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27142423
Direct presynaptic and indirect astrocyte-mediated mechanisms both contribute to endocannabinoid signaling in the pedunculopontine nucleus of mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27169390
Phytocannabinoids and cannabimimetic drugs: recent patents in central nervous system disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27184693
Pharmacological characterization of emerging synthetic cannabinoids in HEK293T cells and hippocampal neurons (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27260125
Effect of synthetic cannabinoids on spontaneous neuronal activity: Evaluation using Ca2+ spiking and multi-electrode arrays (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262380
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27287619
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation driven rat models of Parkinson’s disease (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014488616301790
Ischemic Stroke, Excitatory Amino Acids Toxicity and the Adjustment of Acupuncture Intervention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27323449
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334610
Microglia activation states and cannabinoid system: Therapeutic implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27373505
Expression of the Endocannabinoid Receptor 1 in Human Stroke: An Autoptic Study  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27425766
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor  URB597 may protect against cognitive impairment in rats of chronic cerebral
hypoperfusion via PI3K/AKT signaling (abst–2016) 
http://www.sciencedirect.com/science/article/pii/S0166432816304375
Regulated endosomal trafficking of Diacylglycerol lipase alpha (DAGLα) generates
distinct cellular pools; implications for endocannabinoid signaling (abst–2016)
http://www.sciencedirect.com/science/article/pii/S104474311630135X
Cannabinoids: Glutamatergic Transmission and Kynurenines (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27651254
Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids (abst-2016) http://www.sciencedirect.com/science/article/pii/S0018506X16301799
Functions of synapse adhesion molecules neurexin/neurexins and neurodevelopmental disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/S0168010216301419
Interaction between hippocampal serotonin and cannabinoid systems in reactivity to spatial and object novelty detection (abst–2016) http://www.sciencedirect.com/science/article/pii/S016643281630715X
CB1
Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity  Changes During Nicotine Withdrawal (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27737762
Chronic stress leads to epigenetic dysregulation of neuropeptide-Y and cannabinoid CB1 receptor in the mouse cingulate cortex (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0028390816304580

Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757991
Descending serotonergic and noradrenergic systems do not regulate the antipruritic effects of cannabinoids (abst–2016) https://www.cambridge.org/core/journals/acta-neuropsychiatrica/article/descending-serotonergic-andnoradrenergic-systems-do-not-regulate-the-antipruritic-effects-ofcannabinoids/5BE6C9C7BA28268807D522354F70199A
The central cannabinoid receptor type-2 (CB2) and chronic pain (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27842450
Regulation of fear extinction by long-term depression: the roles of endocannabinoids and  brain derived neurotrophic factor (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27867101
The cannabinoid beta-caryophyllene (BCP) induces neuritogenesis in PC12 cells by a  cannabinoid-receptor-independent mechanism (abst–2016) http://www.sciencedirect.com/science/article/pii/S0009279716305920
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524
Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27918106
Inhibitors of oxidative and hydrolytic endocannabinoid degradation do not enhance depolarization-induced suppression of excitation on dorsal cochlear nucleus glycinergic neurons (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27997730
Synaptic Reorganization of the Perisomatic Inhibitory Network in Hippocampi of Temporal Lobe Epileptic Patients (full–2017) https://www.hindawi.com/journals/bmri/2017/7154295/
A Pulsed Electromagnetic Field Protects against Glutamate-Induced Excitotoxicity by  Modulating the Endocannabinoid System in HT22 Cells (full–2017)  http://journal.frontiersin.org/article/10.3389/fnins.2017.00042/full
Inflammatory Regulation by Driving Microglial M2 Polarization: Neuro-protective Effects of Cannabinoid Receptor-2 Activation in Intracerebral Hemorrhage (full–2017) http://journal.frontiersin.org/article/10.3389/fimmu.2017.00112/full
Neuroprotective effect of WIN55,212-2 against 3-nitropropionic acid-induced toxicity in the rat brain: involvement of CB1 and NMDA receptors (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340665/
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of  Mesial Temporal Lobe Epilepsy (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00131/full
Altered striatal endocannabinoid signaling in a transgenic mouse model of  spinocerebellar ataxia type-3 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407801/
Endocannabinoid signaling in hypothalamic circuits regulates arousal from general  anesthesia in mice (full–2017) https://www.jci.org/articles/view/91038
Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a  Murine Model of Parkinson’s Disease Induced by MPTP (full–2017)  http://www.mdpi.com/1424-8247/10/3/60/htm
Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and  peripheral nervous system (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0181064
Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of  neuronal damage induced by HIV-1 Tat protein (full–2017)  http://www.sciencedirect.com/science/article/pii/S1044743117300830?via%3Dihub
A novel crosstalk within the endocannabinoid system controls GABA transmission in the  striatum (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544685/
Addictive neurons (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479441/
Interaction between Cannabinoid Type 1 and Type 2 Receptors in the Modulation of  Subventricular Zone and Dentate Gyrus Neurogenesis (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00516/full
Cannabinoids in Parkinson’s Disease (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436333 /
Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions  through conditional genetic rescue in forebrain GABAergic neurons (full–2017)  https://link.springer.com/article/10.1007%2Fs00429-017-1411-5
Cannabinoid type 1 receptor-containing axons innervate NPY/AgRP neurons in the  mouse arcuate nucleus (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369208/
Cannabinoid Receptor Signaling in Central Regulation of Feeding Behavior: A Mini Review (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442223/
Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum. (link to download–2017) http://www.nature.com/npp/journal/vaop/naam/abs/npp201712a.html
CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ9-
Tetrahydrocannabinol (Δ9-THC)-Induced Aversive Effects in Mice (full–2017)  https://www.nature.com/articles/s41598-017-12399-z
Cannabinoids disrupt memory encoding by functionally isolating hippocampal CA1 from CA3 (full–2017) http://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1005624
Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid Dependent Lipid Signaling (full–2017) http://www.cell.com/neuron/fulltext/S0896-6273(17)30109-5
Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407663/
The Epac-phospholipase Cε pathway regulates endocannabinoid signaling and cocaine induced disinhibition of VTA dopamine neurons (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354337/
N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with  Widespread Physiological and Pharmacological Activities (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627668/
Regulation of human glioblastoma cell death by combined treatment of cannabidiol,
γ-radiation and small molecule inhibitors of cell signaling pathways (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650324/
The Endocannabinoid System Differentially Regulates Escape Behavior in Mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655002/
Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to  cannabinoid-induced effects (full–2017)  http://www.sciencedirect.com/science/article/pii/S0024320517306069?via%3Dihub
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference (full–2017)  https://www.nature.com/articles/s41598-017-17796-y
Dual Influence of Endocannabinoids on Long-Term Potentiation of Synaptic
Transmission (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742107/
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic  disease (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685274/
Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through  amygdala long-term depression in male rodents (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487270/
Cannabinoid Receptors Modulate Neuronal Morphology and AnkyrinG Density at the  Axon Initial Segment (full–2017)  http://journal.frontiersin.org/article/10.3389/fncel.2017.00005/full
Endocannabinoid-dependent disinhibition of orexinergic neurons: Electrophysiological evidence in leptin-knockout obese mice (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444110/
Endocannabinoid-specific impairment in synaptic plasticity in striatum of Huntington’s disease mouse model (full–2017)
http://www.jneurosci.org/content/38/3/544.long
ESSENTIAL DIETARY BIOACTIVE LIPIDS IN NEUROINFLAMMATORY DISEASES (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984567/
2-arachidonoylglycerol reduces proteoglycans and enhances remyelination in a
progressive model of demyelination (full–2017)
http://www.jneurosci.org/content/37/35/8385.long
Brain cannabinoid receptor 2: expression, function and modulation (full-2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342669/
Antihyperalgesic effect of CB1 receptor activation involves the modulation of P2X3
receptor in the primary afferent neuron (full–2017)
https://www.sciencedirect.com/science/article/pii/S0014299917300407?via%3Dihub
CRIP1a inhibits endocytosis of G-protein coupled receptors activated by  endocannabinoids and glutamate by a common molecular mechanism (full–2017)
https://onlinelibrary.wiley.com/doi/full/10.1111/jnc.14021
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA
10-2474 (full–2017) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641481/
Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor Independent Mechanisms (full–2017)
https://www.frontiersin.org/articles/10.3389/fphar.2017.00720/full
THC Treatment Alters Glutamate Receptor Gene Expression in Human Stem Cell Derived Neurons (full–2017) https://www.karger.com/Article/FullText/477762
CB1 Receptors Signaling in the Brain: Extracting Specificity from Ubiquity (link to PDF–2017) http://www.nature.com/npp/journal/vaop/naam/abs/npp2017206a.html?foxtrotcallback=true
Peripheral inflammation alters N-arachidonoylphosphatidylethanolamine (20:4-NAPE) induced modulation of nociceptive spinal cord synaptic transmission (link to PDF–2017) https://spiral.imperial.ac.uk:8443/handle/10044/1/48351
Expression of Type I Cannabinoid Receptors at Different Stages of Neuronal Differentiation of Human Fibroblasts (1st page–2017)
https://link.springer.com/article/10.1007%2Fs10517-017-3782-2

(S)Pot on Mitochondria: Cannabinoids Disrupt Cellular Respiration to Limit Neuronal Activity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28076767

N-Oleoylglycine-induced hyperphagia was associated with the activation of AgRP neuron by CB1R (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28102080
Effect of inhibition of fatty acid amide hydrolase on MPTP-induced dopaminergic neuronal damage (abst in English–2017) https://www.ncbi.nlm.nih.gov/pubmed/28104279 (full in Spanish)
http://www.elsevier.es/es-revista-neurologia-295-avance-efecto-del-inhibidor-amida-hidrolasa-S0213485316302493

Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28115138
Extinction of avoidance behavior by safety learning depends on endocannabinoid  signaling in the hippocampus (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28222356
A selective CB2R agonist (JWH133) restores neuronal circuit after Germinal Matrix  Hemorrhage in the preterm via CX3CR1+ microglia (abst–2017)  http://www.sciencedirect.com/science/article/pii/S002839081730028X
Cortical adrenoceptor expression, function and adaptation under conditions of  cannabinoid receptor deletion (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0014488617300705
Undercover Power of Endocannabinoids: Postsynaptic Ion-Channel Modulator (abst–2017) http://www.cell.com/neuron/abstract/S0896-6273(17)30197-6
CB1 receptors downregulate a cAMP/Epac2/PLC pathway to silence the nerve terminals  of cerebellar granule cells (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28445587
Endocannabinoid modulation of dopamine neurotransmission (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301831
Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit  composition: A biomarker axis in stress-induced cognitive and emotional impairment  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28456011
Continuous Intrathecal Infusion of Cannabinoid Receptor Agonists Attenuates Nerve  Ligation-Induced Pain in Rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28492437
N-stearoyltyrosine protects primary cortical neurons against oxygen-glucose deprivation induced apoptosis through inhibiting anandamide inactivation system (abst–2017) http://www.sciencedirect.com/science/article/pii/S0168010217300123
Inhibition of SENP3 by URB597 ameliorates neurovascular unit dysfunction in rats with  chronic cerebral hypoperfusion (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28501776
Examining Cholinergic Synaptic Signaling in the Thalamic Reticular Nucleus (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28572192
Synaptic functions of endocannabinoid signaling in health and disease (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817302861
Cannabinoid reward and aversion effects in the posterior ventral tegmental area are  mediated through dissociable opiate receptor subtypes and separate amygdalar and  accumbal dopamine receptor substrates (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28669034
The excitatory/inhibitory input to orexin/hypocretin neuron soma undergoes day / night reorganization (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28669028
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain  Development (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28685756
Chronic CB1 cannabinoid receptor antagonism persistently increases dendritic spine  densities in brain regions important to zebra finch vocal learning and production in an  antidepressant-sensitive manner (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28743448
Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based  Neuroprotective Therapies (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28750802
Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1  simultaneously to modulate colonic motility and visceral sensation in the mouse: A  pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT) (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28695708
Cannabinoids and Pain: Sites and Mechanisms of Action (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28826543
Increase in cortical endocannabinoid signaling in a rat model of basal forebrain  cholinergic dysfunction (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28827178
Could serum S100B be a predictor of neuronal damage and clinical poor outcomes  associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of  SC in the ED (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28867154
Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse  hippocampus (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28888955
Neuronal nitric oxide synthase is involved in CB/TRPV1 signalling: Focus on control of  hippocampal hyperexcitability (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29035821
Activation of cannabinoid receptor 1 is involved in protection against mitochondrial  dysfunction and cerebral ischaemic tolerance induced by isoflurane preconditioning (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29045576
Fatty acid amide hydrolase inhibitor URB597 may protect against kainic acid-induced  damage to hippocampal neurons: Dependence on the degree of injury (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28963903
Impact of dietary fats on brain functions (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29046155
Cannabinoid receptor 1/2 double-knockout mice develop epilepsy (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29105060
Endocannabinoid-Mediated Potentiation of Non-Nociceptive Synapses Contributes to  Behavioral Sensitization (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29118192
CB1 Receptors Mediated Inhibition of ATP-Induced [Ca2+]i Increase in Cultured Rat  Spinal Dorsal Horn Neurons (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29127599
Cannabinoid Receptor Type 1 Agonist ACEA Protects Neurons from Death and
Attenuates Endoplasmic Reticulum Stress-Related Apoptotic Pathway Signaling
(abst–2017) https://link.springer.com/article/10.1007%2Fs12640-017-9839-1
Enantiomer-specific positive allosteric modulation of CB1 signaling in autaptic  hippocampal neurons (abst–2017)  http://www.sciencedirect.com/science/article/pii/S104366181730871X?via%3Dihub
LEARNING-INDUCED MODULATION OF THE EFFECT OF ENDOCANNABINOIDS ON INHIBITORY SYNAPTIC TRANSMISSION (abst-2017) https://www.ncbi.nlm.nih.gov/pubmed/29167327
Adolescent ethanol intake alters cannabinoid type-1 receptor localization in astrocytes of the adult mouse hippocampus (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29168269
Short-term high-fat diet primes excitatory synapses for long-term depression in orexin  neurons (abst–2017)  http://onlinelibrary.wiley.com/doi/10.1113/JP275177/abstract
Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of  Dopamine Release in the Nucleus Accumbens (abst–2017)  http://www.cell.com/neuron/fulltext/S0896-6273(17)31065-6
Cannabidiol Regulates Long Term Potentiation Following Status Epilepticus: Mediation by Calcium Stores and Serotonin (full–2018)
https://www.frontiersin.org/articles/10.3389/fnmol.2018.00032/full
Positron emission tomography imaging of cerebral glucose metabolism and type 1
cannabinoid receptor availability during temporal lobe epileptogenesis in the amygdala kindling model in rhesus monkeys (full–2018)
https://onlinelibrary.wiley.com/doi/full/10.1111/epi.14059
Activity-dependent modulation of hippocampal synaptic plasticity via PirB and
endocannabinoids (full–2018) 
https://www.nature.com/articles/s41380-018-0034-4
Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure (full–2018) http://www.mdpi.com/1424-8247/11/2/50
Endocannabinoids in Body Weight Control (full–2018)
http://www.mdpi.com/1424-8247/11/2/55/htm
Expression and localization of CB1R, NAPE-PLD, and FAAH in the vervet monkey
nucleus accumbens (full–2018) 
https://www.nature.com/articles/s41598-018-26826-2
Endocannabinoid Signaling at Hypothalamic Steroidogenic Factor-
1/Proopiomelanocortin Synapses Is Sex- and Diet-Sensitive (full–2018)
https://www.frontiersin.org/articles/10.3389/fnmol.2018.00214/full
Motor neuron development in zebrafish is altered by brief (5-hr) exposures to THC (∆9-tetrahydrocannabinol) or CBD (cannabidiol) during gastrulation (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043604/
In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive
Cannabinoid (full-2018) 
http://www.mdpi.com/1422-0067/19/7/1992/htm
Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of
Neuronal Activity-Related Diseases (full–2018) 
http://www.mdpi.com/1420-3049/23/7/1526/htm
Selective effects of Δ9-tetrahydrocannabinol on medium spiny neurons in the striatum (full–2018) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0200950

Cannabinoid 1 receptor signaling on GABAergic neurons influences astrocytes in the ageing brain (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095551/

Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS (full–2018) https://www.sciencedirect.com/science/article/pii/S0028390818305082?via%3Dihub

Adolescent exposure to Δ9-tetrahydrocannabinol alters the transcriptional trajectory and dendritic architecture of prefrontal pyramidal neurons (full–2018) https://www.nature.com/articles/s41380-018-0243-x

Neural stem cell lineage-specific cannabinoid type-1 receptor regulates neurogenesis and plasticity in the adult mouse hippocampus (full–2018) https://academic.oup.com/cercor/advance-article/doi/10.1093/cercor/bhy258/5126794

Neuromodulation of Synaptic Transmission in the Main Olfactory Bulb (full–2018) https://www.mdpi.com/1660-4601/15/10/2194/htm

The spatiotemporal expression changes of CB2R in the hippocampus of rats following pilocarpine-induced status epilepticus (full–2018) https://www.sciencedirect.com/science/article/pii/S0920121118302201?via%3Dihub
Adolescent synthetic cannabinoid exposure produces enduring changes in dopamine
neuron activity in a rodent model of schizophrenia susceptibility (link to PDF–2018)
https://academic.oup.com/ijnp/advance-article/doi/10.1093/ijnp/pyy003/4796858
Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients (full–2018) https://www.tandfonline.com/doi/full/10.1080/21678421.2018.142545
Fatty-acid–binding protein 5 controls retrograde endocannabinoid signaling at central glutamate synapses (full–2018) http://www.pnas.org/content/early/2018/03/07/1721339115.long

Cannabinoid WIN-55,212-2 mesylate inhibits tumor necrosis factor-α-induced expression of nitric oxide synthase in dorsal root ganglion neurons (full–2018) https://www.spandidos-publications.com/10.3892/ijmm.2018.3687

Cannabidiol’s Upregulation of N-acyl Ethanolamines in the Central Nervous System Requires N-acyl Phosphatidyl Ethanolamine-Specific Phospholipase D (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277981/

CB2 receptor antibody signal specificity: correlations with the use of partial CB2-knockout mice and anti-rat CB2 receptor antibodies (link to PDF–2018) https://www.researchgate.net/publication/326120461_CB_2_receptor_antibody_signal_specificity_correlations_with_the_use_of_partial_CB_2_-knockout_mice_and_anti-rat_CB_2_receptor_antibodies

Oleoylethanolamide and Palmitoylethanolamide Protect Cultured Cortical Neurons Against Hypoxia (link to PDF–2018) https://www.researchgate.net/publication/327784075_Oleoylethanolamide_and_Palmitoylethanolamide_Protect_Cultured_Cortical_Neurons_Against_Hypoxia

Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity (link to PDF–2018) https://www.researchgate.net/publication/324678254_Paraneoplastic_cerebellar_degeneration_Yo_antibody_alters_mitochondrial_calcium_buffering_capacity

Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson’s disease (link to PDF–2018) https://www.researchgate.net/publication/325802100_Dopamine_D2_receptor_activation_potently_inhibits_striatal_glutamatergic_transmission_in_a_G2019S_LRRK2_genetic_model_of_Parkinson%27s_disease

Cannabidiol inhibits endocannabinoid signaling in autaptic hippocampal neurons (click “aspetjournals” for download–2018) https://scholar.google.com/scholar?q=Cannabidiol+Inhibits+Endocannabinoid+Signaling+in+Autaptic+Hippocampal+Neurons.&hl=en&as_sdt=0&as_vis=1&oi=scholart

Cannabis cures the spine (article–2018) https://www.jtcvs.org/article/S0022-5223(18)32080-4/fulltext

Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative (abst–2018) https://www.sciencedirect.com/science/article/pii/S0028390818304830
Cannabinoids and glial cells: possible mechanism to understand schizophrenia  (abst–2018) https://www.semanticscholar.org/paper/Cannabinoids-and-glial-cells%3A-possible-mechanism-to-Almeida-Martins-deSouza/def584a15611061b5dfb80190421e150e7a3b491
Role of Striatal Direct Pathway 2-Arachidonoylglycerol Signaling in Sociability and
Repetitive Behavior (abst–2018) 
https://www.ncbi.nlm.nih.gov/pubmed/29458998
Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer’s Disease  (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29574668
N-Docosahexaenoylethanolamine: A neurotrophic and neuroprotective metabolite of
docosahexaenoic acid (abst–2018) 
https://www.sciencedirect.com/science/article/pii/S0098299718300244
Phyto and endocannabinoids exert complex actions on calcium and zinc signaling in  mouse cortical neurons (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0006295218301461
Orexin-A and endocannabinoid signaling regulate glucose-responsive arcuate nucleus neurons and feeding behavior in obese rats (abst–2018)  http://www.neuropeptidesjournal.com/article/S0143-4179(17)30254-8/fulltext
Huntington’s disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1 (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0197018618301062
β-Caryophyllene (BCP) ameliorates MPP+ induced cytotoxicity (abst–2018)
https://www.sciencedirect.com/science/article/abs/pii/S0753332217370269
Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative
Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset
Alzheimer’s Disease (abst–2018)
https://link.springer.com/article/10.1007%2Fs40263-018-0515-7
Exposure to cannabinoid agonist WIN 55,212-2 during early adolescence increases
alcohol preference and anxiety in CD1 mice (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0028390818302417
The biomedical challenge of neurodegenerative disorders: an opportunity for
cannabinoid-based therapies to improve on the poor current therapeutic outcomes  (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29856067
Effect of endocannabinoid signalling on cell fate: life, death,
differentiation and proliferation of brain cells (abst–2018) 
https://www.ncbi.nlm.nih.gov/pubmed/29797438
Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors
Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic
Pain (abst–2018) 
https://www.ncbi.nlm.nih.gov/pubmed/29863609
Cannabidiol did not induce teratogenicity or neurotoxicity in exposed zebrafish embryos (abst–2018) https://www.sciencedirect.com/science/article/pii/S0009279718302163?via%3Dihub
Interactions of endocannabinoid virodhamine and related analogs with human
monoamine oxidase-A and –B (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0006295218302375
Deregulation of the endocannabinoid system and therapeutic potential of ABHD6
blockade in the cuprizone model of demyelination (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303113?via%3Dihub

Long-Term Depression Induced by Optogenetically Driven Nociceptive Inputs to Trigeminal Nucleus Caudalis or Headache Triggers (abst–2018) http://www.jneurosci.org/content/38/34/7529.long

Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303198

Anticonvulsant and Neuroprotective Effects of Cannabidiol During the Juvenile Period (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30169677

Toxic leukoencephalopathy with extrapyramidal dysfunction due to synthetic cannabinoids (abst–2018) https://www.sciencedirect.com/science/article/pii/S0967586818307914

Major Contribution of Somatostatin-Expressing Interneurons and Cannabinoid Receptors to Increased GABA Synaptic Activity in the Striatum of Huntington’s Disease Mice (full–2019) https://www.frontiersin.org/articles/10.3389/fnsyn.2019.00014/full

Alterations in synaptic function and plasticity in Huntington disease (full–2019) https://onlinelibrary.wiley.com/doi/full/10.1111/jnc.14723

Protective Effect of N-Arachidonoyl Glycine-GPR18 Signaling after Excitotoxical Lesion in Murine Organotypic Hippocampal Slice Cultures (full–2019) https://www.mdpi.com/1422-0067/20/6/1266/htm

Investigating the Therapeutic Mechanism of Cannabidiol in a Human Induced Pluripotent Stem Cell (iPSC)-Based Cellular Model of Dravet Syndrome (download–2019) http://symposium.cshlp.org/content/early/2019/06/11/sqb.2018.83.038174.long

Effects of chronic cannabinoid exposure during adolescence on reward preference and mPFC activation in adulthood (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S0031938418310965?via%3Dihub

Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ9-Tetrahydrocannabinol-Induced Cognitive Impairment (abst–2019) https://link.springer.com/article/10.1007%2Fs12035-018-1456-3

Supplementation of Cannabis sativa L. leaf powder accelerates functional recovery and ameliorates haemoglobin level following an induced injury to sciatic nerve in mouse model (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31103973

CB1 Receptors in the Anterior Piriform Cortex Control Odor Preference Memory (abst–2019) https://www.cell.com/current-biology/fulltext/S0960-9822(19)30768-7?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0960982219307687%3Fshowall%3Dtrue

CB1 and CB2 receptors play differential roles in early zebrafish locomotor development (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31253713


NEUROPATHIC PAIN*+
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full–2015) http://www.jneuroinflammation.com/content/pdf/s12974-014-0216-1.pdf
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/pme.12569/full
Cannabis in cancer care (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.108/full
Coadministration of indomethacin and minocycline attenuates established paclitaxel induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors (full–2015) http://www.nature.com/srep/2015/150618/srep10541/pdf/srep10541.pdf
Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541447/
Role of the Endocannabinoid System in Diabetes and Diabetic Complications (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13226/full
CB1 Knockout Mice Unveil Sustained CB2-Mediated Anti-Allodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain  (full–2015) http://molpharm.aspetjournals.org/content/88/1/64.long
Selective Monoacylglycerol Lipase Inhibitors: Antinociceptive versus Cannabimimetic Effects in Mice (full–2015)  http://jpet.aspetjournals.org/content/353/2/424.full.pdf+html
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review (full–2015) http://jama.jamanetwork.com/article.aspx? articleid=2338266
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152762/ 
A Cannabinoid CB1 Receptor Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with no Psychoactive Effects (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864630/
Spinal RGS4 inhibition effectively attenuates neuropathic hyperalgesia and restores cannabinoid receptor type 1 signaling (full–2015)  http://onlinelibrary.wiley.com/doi/10.1111/bph.13324/full
Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666747/
Cannabis in cancer care (full–2015) http://escholarship.org/uc/item/6367m6vj#page-1
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604175/
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats (full–2015) http://www.cps.org.tw/files/201503160252300.pdf
Medical marijuana: Hints of headway? Despite a conflicted regulatory landscape, support for medical marijuana is growing amid increasing evidence of potential benefits (Part 2 of 2) (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21524/full
The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuropathic Pain: A Systematic Review (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25635955
Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25712641
CB1 receptors modulate affective behaviour induced by neuropathic pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863168
top
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26058312
Clinical pharmacology of medical cannabinoids in chronic pain (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26267945
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26325482
The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26465930
Analysis of the anti-allodynic effects of combination of a synthetic cannabinoid and a selective noradrenaline re-uptake inhibitor in nerve injury-induced neuropathic mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26206340
Prescribing medical cannabis in Canada: Are we being too cautious? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26451996
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic  Review of Randomized Controlled Trials (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25796592
Emerging concepts of pain therapy based on neuronal mechanisms (abst–2015)  http://link.springer.com/chapter/10.1007%2F978-3-662-46450-2_1
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/bph.13337/full
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887712/
Neuropathic Pain Treatment: Still a Challenge (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935814/
Cannabinoid Buccal Spray for Chronic Non-Cancer or Neuropathic Pain: A Review of Clinical Effectiveness, Safety, and Guidelines (full–2016) https://www.ncbi.nlm.nih.gov/books/NBK395789/
A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis (full–2016)  https://www.dovepress.com/a-preliminary-evaluation-of-the-relationship-of-cannabinoid-blood-conc-peer-reviewed-fulltext-articleJPR
Opioid and cannabinoid synergy in a mouse neuropathic pain model (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959956/
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the  Treatment of Neuropathic Pain from Spinal Cord Injury and Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007175/
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and  Neurophysiological Assessment in Multiple Sclerosis (full–2016)
https://academic.oup.com/painmedicine/article/17/6/1145/1752844
Inflammation of peripheral tissues and injury to peripheral nerves induce diferring effects in the expression of the calcium-sensitive anandamide-synthesising enzyme and related molecules in rat primary sensory neurons (link to PDF–2016)
https://spiral.imperial.ac.uk:8443/handle/10044/1/43081
The selective monoacylglycerol lipase inhibitor MJN110 produces opioid sparing effects in a mouse neuropathic pain model (link to PDF–2016) http://jpet.aspetjournals.org/content/early/2016/01/20/jpet.115.229971.abstract?sid=97527854 -e2fb-4d74-ad96-6ab0744dc240

Using Medical Cannabis in an Oncology Practice (article–2016) (needs free registration) http://www.cancernetwork.com/oncology-journal/using-medical-cannabis-oncologypractice#sthash.CjT8fR9n.uWvEhfSG.dpuf
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst in English & German–2016) https://link.springer.com/article/10.1007%2Fs00482-015-0083-4
The endocannabinoid system and neuropathic pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26785153
Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain : A systematic review of randomized controlled studies (abst in German & English-2016) http://link.springer.com/article/10.1007%2Fs00482-015-0089-y

Cannabinoids and autoimmune diseases: A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876387
Nabilone for the Management of Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26923810
Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: a Dietary Phytocannabinoid of Pharmaceutical Promise (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26965491
Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy (abst–2016) http://www.sciencedirect.com/science/article/pii/S002839081630079X
The role of carbon monoxide on the anti-nociceptive effects and expression of cannabinoid 2 receptors during painful diabetic neuropathy in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27020787
Mesoporous Silica Particles as a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27028159
Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27214593

The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816305667
Cannabinoids for the treatment of neuropathic pain (abst–2016) http://www.ingentaconnect.com/search/article?option1=title&value1=Cannabinoids+for+the+treatment+of+neuropathic+pain.&pageSize=10&index=1

Peripherally selective cannabinoid 1 receptor (CB1R) agonists for the treatment of neuropathic pain (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00516
Progress in study on endocannabinoids and cannabinoid receptors in the treatment for neuropathic pain (abst in English, link to full in Chinese–2016)
http://www.ncbi.nlm.nih.gov/pubmed/27600019

Activation of Cannabinoid Receptor 2 Attenuates Mechanical Allodynia and Neuroinflammatory Responses in a Chronic Post-Ischemic Pain Model of Complex Regional Pain Syndrome Type I in Rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27717112
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816305123
Antihyperalgesic Activities of Endocannabinoids in a Mouse Model of Antiretroviral Induced Neuropathic Pain (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357623/
Rimonabant improves metabolic parameters partially attributed to restoration of high  voltage-activated Ca2+ channels in skeletal muscle in HFD-fed mice (full–2017)  http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000600602&lng=en&nrm=iso&tlng=en (full–in varous languages)  http://www.scielo.br/scieloOrg/php/translate.php?pid=S0100-879X2017000600602&caller=www.scielo.br&lang=en&tlang=en&script=sci_arttext
The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697682/
The Clinical Significance of Endocannabinoids in Endometriosis Pain Management  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436335/
Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12  and P2Y13 receptors in neuropathic pain rats (full–2017)  https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0960-0
Cannabinoids in Pain Management and Palliative Medicine (full–2017)  https://www.aerzteblatt.de/int/archive/article?id=193441
N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with  Widespread Physiological and Pharmacological Activities (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627668/
Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430528/
Pharmacologic management of chronic neuropathic pain (full–2017)  http://www.cfp.ca/content/63/11/844.long
Modulating the endocannabinoid pathway as treatment for peripheral neuropathic pain: a selected review of preclinical studies (full–2017)  http://apm.amegroups.com/article/view/16320/16484
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference (full–2017)  https://www.nature.com/articles/s41598-017-17796-y
Chapter 4 Neuropathic Pain in Multiple Sclerosis—Current Therapeutic Intervention and  Future Treatment Perspectives (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK470151/
WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759843/
Upregulation of fatty acid amide hydrolase in the dorsal periaqueductal gray is associated with neuropathic pain and reduced heart rate in rats (full–2017)
https://www.physiology.org/doi/full/10.1152/ajpregu.00481.2016
The Inhibitory Effects of Cobalt Protoporphyrin IX and Cannabinoid 2 Receptor
Agonists in Type 2 Diabetic Mice (full–2017) 
http://www.mdpi.com/1422-0067/18/11/2268/htm
The slowly signaling G protein-biased CB2 cannabinoid receptor agonist LY2828360  suppresses neuropathic pain with sustained efficacy and attenuates morphine tolerance  and dependence (link to download–2017)  http://molpharm.aspetjournals.org/content/early/2017/11/30/mol.117.109355.long

Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and  Meta-Analysis of Randomized Controlled Trials (link to PDF-2017)  http://www.painphysicianjournal.com/linkout?issn=1533-3159&vol=20&page=E755
Systematic review of safeness and therapeutic efficacy of cannabis in patients with  multiple sclerosis, neuropathic pain, and in oncological patients treated with  chemotherapy (abst in English–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29119763  (full in Italian)  http://www.epiprev.it/articolo_scientifico/revisione-sistematica-sull%E2%80%99efficacia-terapeutica-e-la-sicurezza-della-cannabis
Role of cannabinoid receptor 1-mediated synaptic plasticity in neuropathic pain and
associated depression (abst in English, click “Full Text Links” for full in Chinese–2017) 
https://www.ncbi.nlm.nih.gov/pubmed/28364110
Endocannabinoid activation of CB1 receptors contributes to long-lasting reversal of  neuropathic pain by repetitive spinal cord stimulation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28107590
Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-
Tetrahydrocannabinol in Patients With Progressive Multiple Sclerosis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28189366
Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE) (abst–2017) http://www.sciencedirect.com/science/article/pii/S1043661817301536
Continuous Intrathecal Infusion of Cannabinoid Receptor Agonists Attenuates Nerve
Ligation-Induced Pain in Rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28492437
Neuroprotection in oxidative stress-related neurodegenerative diseases: role of  endocannabinoid system modulation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28497982
Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Metaanalysis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28537982
Single and combined effects of delta9 -tetrahydrocannabinol and cannabidiol in a mouse  model of chemotherapy-induced neuropathic pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28548225
Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in  mice (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817303465?via%3Dihub
Single oral dose of cannabinoid derivate loaded PLGA nanocarriers relieves neuropathic  pain for eleven days (abst–2017)  http://www.nanomedjournal.com/article/S1549-9634(17)30140-5/fulltext
Cannabinoids and Pain: Sites and Mechanisms of Action (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28826543
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating  Inflammatory and Neuropathic Pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28857069
Managing neuropathic pain in multiple sclerosis: Pharmacological interventions (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28875858
Cannabis constituent synergy in a mouse neuropathic pain model (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28885457
Liposomal Delivery of Diacylglycerol Lipase-Beta Inhibitors to Macrophages  Dramatically Enhances Selectivity and Efficacy in Vivo (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00657
The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces  analgesia in mice (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28963716
Salvinorin A reduces neuropathic nociception in the insular cortex of the rat (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28975684
Neuropathic pain treatment (abst in English & French–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28981225
In vitro and in vivo pharmacological characterization of ASP8477: A novel highly  selective fatty acid amide hydrolase inhibitor (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29017758
Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the  Treatment of Diabetic Nephropathy (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29030466
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain  management – An overview of systematic reviews (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29034533
Current evidence of cannabinoid-based analgesia obtained in preclinical and human
experimental settings (abst–2017) 
https://www.ncbi.nlm.nih.gov/pubmed/29160600
Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases (full–2018)  https://www.dovepress.com/pharmacotherapeutic-considerations-for-use-of-cannabinoids-to-relieve–peer-reviewed-fulltext-articleJPR
Including cannabinoids in the treatment of painful schwannomatosis (full–2018)
https://onlinelibrary.wiley.com/doi/full/10.1002/brb3.1011
Pain Modulation after Oromucosal Cannabinoid Spray (SATIVEX®) in Patients with
Multiple Sclerosis: A Study with Quantitative Sensory Testing and Laser-Evoked  Potentials (full–2018) 
http://www.mdpi.com/2305-6320/5/3/59/htm
Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy (full–2018)  https://www.dovepress.com/cannabinoids-and-agmatine-as-potential-therapeutic-alternatives-for-ci-peer-reviewed-fulltext-article-JEP
Priority areas for cannabis and cannabinoid product research in South Africa (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018595/

Therapeutic potential of medicinal marijuana: an educational primer for health care
professionals (full–2018) 
https://www.dovepress.com/therapeutic-potential-of-medicinal-marijuana-an-educational-primer-for-peer-reviewed-fulltext-articleDHPS
Willingness to Participate in Longitudinal Research Among People with Chronic Pain
Who Take Medical Cannabis: A Cross-Sectional Survey (full–2018) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870058/
Evidence for the use of “medical marijuana” in psychiatric and neurologic disorders  (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007658/
Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain (full–2018) http://www.mdpi.com/2305-6320/5/3/67/htm
Involvement of leptin signaling in the development of cannabinoid CB2 receptor dependent mirror image pain (full–2018) https://www.nature.com/articles/s41598-018-28507-6
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron (full-2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871676/

Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain (full–2018) https://www.dovepress.com/cannabinoids-and-spinal-cord-stimulation-for-the-treatment-of-failed-b-peer-reviewed-fulltext-article-JPR

The role of cannabinoids in pain control: the good, the bad, and the ugly (full–2018) https://www.minervamedica.it/en/journals/minervaanestesiologica/article.php?cod=R02Y2018N08A0955&html=1&htmlID=20H%2FJ%2FzJfllWbTQgG%2Bvg0sefo5GdruhwhCHuDxoDpD61KdeBk12dKITvfl98aZhJ6Y75DlKXV6PoFp9GqFlPuQ%3D%3D
Cannabinoid WIN-55,212-2 mesylate inhibits tumor necrosis factor-α-induced expression of nitric oxide synthase in dorsal root ganglion neurons (full–2018)  https://www.spandidos-publications.com/10.3892/ijmm.2018.3687

Cannabis for peripheral neuropathy: The good, the bad, and the unknown (full–2018) https://www.mdedge.com/ccjm/article/189782/drug-therapy/cannabis-peripheral-neuropathy-good-bad-and-unknown

Cannabinoids and Pain: New Insights From Old Molecules (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277878/Care After Chemotherapy: Peripheral Neuropathy, Cannabis for Symptom Control, and Mindfulness (full–2018)

https://ascopubs.org/doi/full/10.1200/EDBK_209437?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy Induced Neuropathic Pain: Studies in Animal Models (link to full–2018) https://www.hindawi.com/journals/prm/2018/5234943/

Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase synergize with the opioid analgesic morphine to suppress chemotherapy-induced neuropathic nociception without enhancing effects of morphine on gastrointestinal transit (link to PDF–2018) http://jpet.aspetjournals.org/content/early/2018/10/01/jpet.118.252288.long

Ultra-micronized palmitoylethanolamide rescues the cognitive decline-associated loss of neural plasticity in the neuropathic mouse entorhinal cortex-dentate gyrus pathway (link to PDF–2018) https://www.researchgate.net/publication/327875906_Ultra-micronized_palmitoylethanolamide_rescues_the_cognitive_declineassociated_loss_of_neural_plasticity_in_the_neuropathic_mouse_entorhinal_cortex-dentate_gyrus_pathway

Inhibition of 2-arachydonoylgycerol degradation attenuates orofacial neuropathic pain in trigeminal nerve-injured mice (link to download–2018) https://www.jstage.jst.go.jp/article/josnusd/advpub/0/advpub_17-0005/_article

Monoacylglycerol lipase inhibitors reverse paclitaxel-induced nociceptive behavior and proinflammatory markers in a mouse model of chemotherapy-induced neuropathy (link to download–2018) http://jpet.aspetjournals.org/content/early/2018/03/14/jpet.117.245704

Identification of the first synthetic allosteric modulator of the CB2 receptors and evidence of its efficacy for neuropathic pain relief (click “unifi” for download–2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Identification+of+the+First+Synthetic+Allosteric+Modulator+of+the+CB2+Receptors+and+Evidence+of+Its+Efficacy+for+Neuropathic+Pain+Relief&btnG=

Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain (click “unifi” for download–2018) https://scholar.google.com/scholar?q=Development+of+Potent+Inhibitors+of+Fatty+Acid+Amide+Hydrolase+Useful+for+the+Treatment+of+Neuropathic+Pain.&hl=en&as_sdt=0&as_vis=1&oi=scholart

Cannabinoid therapy in practice (abst in German & English-2018) https://link.springer.com/article/10.1007%2Fs00120-018-0636-0

Cannabinoids in pain medicine (abst in German & English–2018) https://link.springer.com/article/10.1007%2Fs00482-018-0299-1
Endogenous systems involved in exercise-induced analgesia (click “Full Text Links” for download–2018) https://www.ncbi.nlm.nih.gov/pubmed/29769416
Medical Cannabis for Neuropathic Pain (abst–2018)
https://link.springer.com/article/10.1007%2Fs11916-018-0658-8
Mechanisms and treatment of painful neuromas (abst–2018) https://www.degruyter.com/view/j/revneuro.ahead-of-print/revneuro-2017-0077/revneuro-2017-0077.xml
Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29528965
Cannabinoid Receptors, Mental Pain and Suicidal Behavior: a Systematic Review  (abst–2018) https://www.semanticscholar.org/paper/Cannabinoid-Receptors%2C-Mental-Pain-and-Suicidal-a-Colino-HerranzHerrer/b6a2d61fe231a5dc334f6dfe97c16efb8a88221b

Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by
cannabinoids (abst–2018) 
https://www.sciencedirect.com/science/article/pii/S1471489218300043?via%3Dihub
The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0008874918300911
An overview of the cannabinoid type 2 receptor system and its therapeutic potential  (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29794855
Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors
Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic
Pain (abst–2018) 
https://www.ncbi.nlm.nih.gov/pubmed/29863609
Cannabinoids for Treatment of MS Symptoms: State of the Evidence (abst–2018)
https://link.springer.com/article/10.1007%2Fs11910-018-0859-x
Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced  peripheral neuropathy pain symptoms by CB1 receptor activation (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0028390818303575?via%3Dihub
Chronic pain and cannabinoids. Great expectations or a christmas carol (abst–2018)
https://www.sciencedirect.com/science/article/abs/pii/S0006295218303010

Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30157131

Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity (abst–2018) http://n.neurology.org/content/early/2018/09/05/WNL.0000000000006293.long

Bortezomib And Endocannabinoid/Endovanilloid System: A Synergism In Osteosarcoma (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S1043661818310387

THC and gabapentin interactions in a mouse neuropathic pain model (abst–2018) https://www.sciencedirect.com/science/article/pii/S0028390818307779?via%3Dihub

Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55 (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331465/

A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446169/
Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535492/

Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study (full–2019) https://www.cambridge.org/core/journals/palliative-and-supportive-care/article/cannabis-treatment-in-hospitalized-patients-using-thesyqe-inhaler-results-of-a-pilot-openlabel-study/0C1940413E704A7EADCB949F5F49603A/core-reader

Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic Pain (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637694/

Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms (full–2019) https://www.liebertpub.com/doi/full/10.1089/jpm.2018.0658?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed

Lavender (Lavandula angustifolia Mill.) Essential Oil Alleviates Neuropathic Pain in Mice With Spared Nerve Injury (full–2019) https://www.frontiersin.org/articles/10.3389/fphar.2019.00472/full

Therapeutic applications by cannabinoid action/ Aplicaciones terapéuticas por acción de los cannabinoides (abst in English, full in Spanish–2019) http://gacetamedicademexico.com/frame_esp.php?id=310

CB1 positive allosteric modulation attenuates Δ9-THC withdrawal and NSAID-induced gastric inflammation (abst–2019) https://www.sciencedirect.com/science/article/pii/S0091305718305227?via%3Dihub

Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain (abst–2019) https://www.sciencedirect.com/science/article/pii/S0960894X19301428?via%3Dihub

Crossing the Line: Care of a Pediatric Patient with Intractable Seizures and Severe Neuropathic Pain in Absence of Access to Medical Marijuana (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31184974

Cannabis-based medicines for chronic pain management: current and future prospects (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31356363

Associations of PTSD, chronic pain, and their comorbidity on cannabis use disorder: Results from an American nationally representative study (abst–2019) https://onlinelibrary.wiley.com/doi/abs/10.1002/da.22947

Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain (abst–2019) https://link.springer.com/article/10.1007%2Fs40265-019-01132-x

The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review (abst–2019) https://journals.sagepub.com/doi/abs/10.1177/1049909119850807?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=ajhb

Opportunities for cannabis in supportive care in cancer (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31413731

The effectiveness of self-directed medical cannabis treatment for pain (abst-2019) https://www.sciencedirect.com/science/article/abs/pii/S0965229919308040


NEUROPROTECTION*+
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/apha.12474/full
The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K / Akt / mTORC1 / BDNF pathway (full–2015) http://www.nature.com/cdd/journal/vaop/ncurrent/full/cdd201511a.html
Palmitoylethanolamide Inhibits Glutamate Release in Rat Cerebrocortical Nerve Terminals (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394492/
Perinatal asphyxia results in altered expression of the hippocampal acylethanolamide / endocannabinoid signaling system associated to memory impairments in postweaned rats (full–2015) http://journal.frontiersin.org/article/10.3389/fnana.2015.00141/full
New horizons for newborn brain protection: enhancing endogenous neuroprotection (full–2015) http://fn.bmj.com/content/100/6/F541
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic Potentials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607066/
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease (full–2015) http://www.sciencedirect.com/science/article/pii/S0014488615300583
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis (full–2015) http://darujps.biomedcentral.com/articles/10.1186/s40199-015-0131-8
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516969/
The therapeutic potential of cannabinoids for movement disorders (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357541/
Enhancement of endocannabinoid signalling protects against cocaine-induced  neurotoxicity (full–2015)  http://www.sciencedirect.com/science/article/pii/S0041008X15001556
A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507161/
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604192/
Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury from SO2 Inhalation via PPARγ Pathway (full–2015) http://toxsci.oxfordjournals.org/content/147/2/535.long
Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jnc.13288/full
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552583/
Cannabidiol protects an in vitro model of the blood brain barrier (BBB) from oxygenglucose deprivation via PPARγ and 5-HT1A (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761095/
Are the endocannabinoid-like compounds N-acyl aminoacids neuroprotective after  traumatic brain injury? (link to PDF–2015)  http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0092/jbcpp-2015-0092.xml

Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis (link to PDF–2015) http://www.europeanreview.org/article/10049
Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury (link to PDF–2015) https://www.researchgate.net/publication/272835284_Palmitoyl_Serine_An_Endogenous_Neuroprotective_EndocannabinoidLike_Entity_After_Traumatic_Brain_Injury

Ultra-low doses of tetrahydrocannabinol contribute to the survival of newly-born cells in the dentate gyrus of adult rats (2 pages–2015)  http://link.springer.com/article/10.1134/S1819712415030046
On the Role of Astroglial Syncytia in Self-Repairing Spiking Neural Networks (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25576582
Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of Cerebral Malaria (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595981
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst-2015) http://www.sciencedirect.com/science/article/pii/S0024320515000521
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25795598
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer’s Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818503
Monoacylglycerol Lipase Inhibitor Protects Primary Cultured Neurons Against Homocysteine-induced Impairments in Rat Caudate Nucleus through COX-2 signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818189
Protective effect of paeoniflorin on the hippocampus in rats with cerebral ischemia reperfusion through activating cannabinoid receptor 2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25854559
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863279
Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25917763
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?  (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
top
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25963415
Neuroprotective Effect of JZL184 in MPP+-Treated SH-SY5Y Cells Through CB 2 Receptors  (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25976369
Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25989217
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Combined neuroprotective action of adenosine A1 and cannabinoid CB1 receptors against NMDA-induced excitotoxicity in the hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26065937
Effect of Homocysteine on Voltage-Gated Sodium Channel Currents in Primary Cultured Rat Caudate Nucleus Neurons and Its Modulation by 2-Arachidonylglycerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179279
top

Neuroprotective mechanisms of cannabinoids in brain ischemia and neurodegenerative disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26299059
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26408162
Endocannabinoids and Neurodegenerative Disorders: Parkinson’s Disease, Huntington’s Chorea, Alzheimer’s Disease, and Others (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408163
N-Palmitoyl serotonin alleviates scopolamine-induced memory impairment via regulation of cholinergic and antioxidant systems, and expression of BDNF and p-CREB in mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0009279715300697
The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26431622
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411568
The neuroprotection of cannabidiol against MPP+-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson’s disease (abst–2015) http://www.sciencedirect.com/science/article/pii/S0887233315300047
THC exerts neuroprotective effect in glutamate affected murine primary mesencephalic cultures and neuroblastoma N18TG2 cells (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1565754
Neuroprotective effects of trans-caryophyllene against kainic Acid induced seizure  activity and oxidative stress in mice (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25417010
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following  germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815001574
Cannabinoid CB2 Receptor Mediates Nicotine-Induced Anti-Inflammation in N9 Microglial Cells Exposed to β Amyloid via Protein Kinase C (full–2016) http://www.hindawi.com/journals/mi/2016/4854378/
The Endocannabinoid System as a Therapeutic Target in Glaucoma (full–2016) http://www.hindawi.com/journals/np/2016/9364091/
NO2 inhalation promotes Alzheimer’s disease-like progression: cyclooxygenase-2- derived prostaglandin E2 modulation and monoacylglycerol lipase inhibition-targeted medication (full–2016) http://www.nature.com/articles/srep22429
Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview (full–2016) http://www.mdpi.com/1420-3049/21/4/518/htm
Cannabinoid 1 receptor knockout mice display cold allodynia, but enhanced recovery from spared-nerve injury-induced mechanical hypersensitivity (full–2016) http://mpx.sagepub.com/content/12/1744806916649191.long B2
CB2 Cannabinoid Receptor As Potential Target against Alzheimer’s Disease (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00243/full#B36
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids (full–2016) http://www.nature.com/articles/npjamd201612
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=10314&path%5B%5D=32486
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/cns.12506/full
Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by the excess microglia-mediated inflammation (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931157/
VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949444/
Orchestrated activation of mGluR5 and CB1 promotes neuroprotection (full–2016) http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-016-0259-6
Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969295/
Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052277/
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892852/
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis (full–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16304476
Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons (full–2016) http://www.sciencedirect.com/science/article/pii/S221323171630338X
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders  (full–2016) http://www.sciencedirect.com/science/article/pii/S0960894X16306874
Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures  (full–2016) http://www.epilepsybehavior.com/article/S1525-5050(15)00695-2/fulltext
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic  Neurotransmission in Prefrontal Cortex Slices (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848126/
CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a  model of traumatic brain injury (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0014488616300619
Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220555/
CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a
model of traumatic brain injury (abst–2016) 
http://www.sciencedirect.com/science/article/pii/S0014488616300619

Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure (abst–2016) http://link.springer.com/article/10.1007/s12031-015-0703-6 Mn-SOD
Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage  (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26820826
Arachidonyl-2-Chloroethylamide Alleviates Cerebral Ischemia Injury Through Glycogen  Synthase Kinase-3β-Mediated Mitochondrial Biogenesis and Functional Improvement  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26820679
Cannabidiol, neuroprotection and neuropsychiatric disorders (abst–2016)  http://www.sciencedirect.com/science/article/pii/S1043661816000396
Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an  acute rat model of temporal lobe epilepsy (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26970948
Endocannabinoid 2-Arachidonoylglycerol Suppresses LPS-Induced Inhibition of A-Type  Potassium Channel Currents in Caudate Nucleus Neurons Through CB1 Receptor (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27129498
Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting  Neuron from Cerebral Ischemia (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27142423
Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and  advanced stages in the triple transgenic mice model of Alzheimer’s disease (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27223629
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation driven rat models of Parkinson’s disease (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0014488616301790
Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27317835
Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinsońs disease  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27318096

Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334610
The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27373318
A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27450568
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816304375
The cannabinoid receptor agonist WIN55.212 reduces consequences of status epilepticus in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27520083
Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27544303
Neuroprotective Effects of Cannabidiol In Hypoxic Ischemic Insult: The Therapeutic Window In Newborn Mice (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27686886
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with Amyotrophic Lateral Sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27714895
Activation of Cannabinoid Receptor 2 Attenuates Mechanical Allodynia and Neuroinflammatory Responses in a Chronic Post-Ischemic Pain Model of Complex Regional Pain Syndrome Type I in Rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27717112
Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757991
The cannabinoid beta-caryophyllene (BCP) induces neuritogenesis in PC12 cells by a cannabinoid-receptor-independent mechanism (abst–2016) http://www.sciencedirect.com/science/article/pii/S0009279716305920
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524
The arguments for and against cannabinoids application in glaucomatous retinopathy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28027538
CB2 cannabinoid receptors modulate HIF-1α and TIM-3 expression in a hypoxiaischemia  mouse model (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/28253997
A Pulsed Electromagnetic Field Protects against Glutamate-Induced Excitotoxicity by  Modulating the Endocannabinoid System in HT22 Cells (full–2017)  http://journal.frontiersin.org/article/10.3389/fnins.2017.00042/full
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target (full–2017)  http://journal.frontiersin.org/article/10.3389/fnins.2017.00030/full
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer’s Disease (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00020/full
Endocannabinoids: A Promising Impact for Traumatic Brain Injury (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314139/
Neuroprotective effect of WIN55,212-2 against 3-nitropropionic acid-induced toxicity in  the rat brain: involvement of CB1 and NMDA receptors (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340665/
In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke  neuroinflammation in rats: a positron emission tomography study (full–2017)  https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0851-4
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of  Mesial Temporal Lobe Epilepsy (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00131/full
Altered striatal endocannabinoid signaling in a transgenic mouse model of  spinocerebellar ataxia type-3 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407801/
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of  Cannabidiol in Psychiatric Disorders (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00269/full
Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a  Murine Model of Parkinson’s Disease Induced by MPTP (full–2017)  http://www.mdpi.com/1424-8247/10/3/60/htm
Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of  neuronal damage induced by HIV-1 Tat protein (full–2017)  http://www.sciencedirect.com/science/article/pii/S1044743117300830?via%3Dihub
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid (full–2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
Abnormalities in Dynamic Brain Activity Caused by Mild Traumatic Brain Injury Are  Partially Rescued by the Cannabinoid Type-2 Receptor Inverse Agonist SMM-189 (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562300/
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and  Relevant Animal Studies (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of  Vascular Dementia (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460147/
Interplay Between n-3 and n-6 Long-Chain Polyunsaturated Fatty Acids and the  Endocannabinoid System in Brain Protection and Repair (full–2017)  https://link.springer.com/article/10.1007%2Fs11745-017-4292-8
AM1241 alleviates MPTP-induced Parkinson’s disease and promotes the regeneration of  DA neurons in PD mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620217/
(-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor  Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412277/
N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with  Widespread Physiological and Pharmacological Activities (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627668/
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues  for other neuroinflammatory diseases (full–2017)  http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Binge Alcohol Exposure Transiently Changes the Endocannabinoid System: A Potential  Target to Prevent Alcohol-Induced Neurodegeneration (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742761/
Reversal of age-related cognitive impairments in mice by an extremely low dose of  tetrahydrocannabinol (full–2017) http://www.neurobiologyofaging.org/article/S0197-4580(17)30321-4/fulltext
Elevation of arachidonoylethanolamide levels by activation of the endocannabinoid  system protects against colitis and ameliorates remote organ lesions in mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740744/
Extract of Fructus Cannabis Ameliorates Learning and Memory Impairment Induced by –D-Galactose in an Aging Rats Model (full–2017)  https://www.hindawi.com/journals/ecam/2017/4757520/
Endocannabinoid-specific impairment in synaptic plasticity in striatum of Huntington’s disease mouse model (full–2017)  http://www.jneurosci.org/content/38/3/544.long
ESSENTIAL DIETARY BIOACTIVE LIPIDS IN NEUROINFLAMMATORY DISEASES (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984567/
AM1241 alleviates MPTP-induced Parkinson’s disease and promotes the regeneration of DA neurons in PD mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620217/
Up-regulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis (link to download–2017)  http://dmm.biologists.org/content/early/2017/01/06/dmm.028373.long

Neuroprotective properties of endocannabinoids N-arachidonoyl dopamine and Ndocosahexaenoyl dopamine examined in neuronal precursors derived from human pluripotent stem cells (2 pages–2017)  https://link.springer.com/article/10.1134%2FS0006297917110141
Effect of inhibition of fatty acid amide hydrolase on MPTP-induced dopaminergic  neuronal damage (abst in English–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28104279 (full in Spanish)  http://www.elsevier.es/es-revista-neurologia-295-avance-efecto-del-inhibidor-amida-hidrolasa-S0213485316302493
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur  dioxide inhalation via cannabinoid receptors in the brain (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1001074216302340
Therapeutic effects of cannabinoids in animal models of seizures, epilepsy,  epileptogenesis, and epilepsy-related neuroprotection (abst–2017)  http://www.epilepsybehavior.com/article/S1525-5050(16)30531-5/fulltext
A selective CB2R agonist (JWH133) restores neuronal circuit after Germinal Matrix  Hemorrhage in the preterm via CX3CR1+ microglia (abst–2017)  http://www.sciencedirect.com/science/article/pii/S002839081730028X
Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse  model of ALS (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301296?via%3Dihub
The endocannabinoid system, a novel and key participant in acupuncture’s multiple  beneficial effects (abst–2017) http://www.sciencedirect.com/science/article/pii/S0149763417301318
Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit  composition: A biomarker axis in stress-induced cognitive and emotional impairment  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28456011
N-stearoyltyrosine protects primary cortical neurons against oxygen-glucose deprivation induced apoptosis through inhibiting anandamide inactivation system (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0168010217300123
N-stearoyl-l-Tyrosine inhibits the cell senescence and apoptosis induced by H2O2 in  HEK293/Tau cells via the CB2 receptor (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0009279716307293
Activation of CB2 receptor system restores cognitive capacity and hippocampal Sox2  expression in a transgenic mouse model of Alzheimer’s disease (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28551012
Zonisamide ameliorates levodopa-induced dyskinesia and reduces expression of striatal  genes in Parkinson model rats (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0168010217300639
Neuroprotective effects of drug-induced therapeutic hypothermia in central nervous  system diseases (abst–2017)  http://www.eurekaselect.com/152965/article
Perspectives of Cannabinoid type 2 receptor (CB2R) ligands in neurodegenerative  disorders: Structure Affinity Relationship (SAfiR) and Structure Activity Relationship  (SAR) Studies (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.7b00155
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic  stimuli: Possible involvement of the endocannabinoid and endovanilloid systems (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/19591935
The synthetic cannabinoid WIN55212-2 ameliorates traumatic spinal cord injury via  inhibition of GAPDH/Siah1 in a CB2-receptor dependent manner (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28716633
Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP  Transgenic Mice Lacking CB2 Receptors (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28733897
Neuroprotection by (endo)cannabinoids in glaucoma and retinal neurodegenerative  diseases (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28738764
Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based  Neuroprotective Therapies (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28750802
Mouse retinal ganglion cell signalling is dynamically modulated through parallel  anterograde activation of cannabinoid and vanilloid pathways (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28766743
Neuroprotective activity of cannabinoid receptor-2 against oxidative stress and apoptosis in rat pups having experimentally-induced congenital hypothyroidism (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28799288
GPR55: A therapeutic target for Parkinson’s disease? (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817303842
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor  URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28825114
The Role of Nuclear Hormone Receptors in Cannabinoid Function (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28826538
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated  microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and
levodopa-induced dyskinesia (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28843453
Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28853159
Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo  Neurotoxic Effects of Paraoxon (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28803438
Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0014488617302212
Novel therapeutics in glaucoma management (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28925883
Fatty acid amide hydrolase inhibitor URB597 may protect against kainic acid-induced  damage to hippocampal neurons: Dependence on the degree of injury (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28963903
Impact of dietary fats on brain functions (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29046155
Monoacylglycerol lipase inhibitor JZL184 prevents HIV-1 gp120-induced synapse loss by altering endocannabinoid signaling (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29061509
Neuroprotective effect of cannabinoid receptor 1 antagonist in the MNU-induced retinal  degeneration model (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0014483517305080?via%3Dihub
Cannabinoid Receptor Type 1 Agonist ACEA Protects Neurons from Death and  Attenuates Endoplasmic Reticulum Stress-Related Apoptotic Pathway Signaling  (abst–2017) https://link.springer.com/article/10.1007%2Fs12640-017-9839-1
Paeoniflorin exerts neuroprotective effects by modulating the M1/M2 subset polarization of microglia/macrophages in the hippocampal CA1 region of vascular dementia rats via cannabinoid receptor 2 (full–2018)  https://cmjournal.biomedcentral.com/articles/10.1186/s13020-018-0173-1
Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injury (full–2018)  https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1166-9
Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users (full–2018)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908414/
Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse
Model of Acute Epilepsy (full–2018) 
https://www.frontiersin.org/articles/10.3389/fnmol.2018.00067/full
Octadecylpropyl Sulfamide Reduces Neurodegeneration and Restores the Memory
Deficits Induced by Hypoxia-Ischemia in Mice (full–2018) 
https://www.frontiersin.org/articles/10.3389/fphar.2018.00376/full
Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders? (full–2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00482/full
Review of the neurological benefits of phytocannabinoids (full–2018) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938896/
Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831753/
In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive
Cannabinoid (full–2018) 
http://www.mdpi.com/1422-0067/19/7/1992/htm
Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of
Neuronal Activity-Related Diseases (full–2018) 
http://www.mdpi.com/1420-3049/23/7/1526/htm

Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis (full–2018) http://www.mdpi.com/2305-6320/5/3/91/htm
Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS (full–2018) https://www.sciencedirect.com/science/article/pii/S0028390818305082?via%3Dihub

Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor (full–2018) https://molecularbrain.biomedcentral.com/articles/10.1186/s13041-018-0395-2

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age (full–2018) https://www.frontiersin.org/articles/10.3389/fimmu.2018.02009/full

The spatiotemporal expression changes of CB2R in the hippocampus of rats following pilocarpine-induced status epilepticus (full–2018) https://www.sciencedirect.com/science/article/pii/S0920121118302201?via%3Dihub

Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120904/
Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients (full–2018) https://www.tandfonline.com/doi/full/10.1080/21678421.2018.1425454

Role of CB2 Receptor in the Recovery of Mice after Traumatic Brain Injury (full–2018) https://www.liebertpub.com/doi/full/10.1089/neu.2018.6063?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed

Hemp (Cannabis sativa L.) Seed Phenylpropionamides Composition and Effects on Memory Dysfunction and Biomarkers of Neuroinflammation Induced by Lipopolysaccharide in Mice (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288804/

Preventive Effects of Resveratrol on Endocannabinoid System and Synaptic Protein Modifications in Rat Cerebral Cortex Challenged by Bilateral Common Carotid Artery Occlusion and Reperfusion (link to full–2018) http://www.mdpi.com/1422-0067/19/2/426
Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and  Related Comorbidities (link to PDF–2018) https://www.researchgate.net/publication/322709612_Prospects_of_Cannabidiol_for_Easing_Status_EpilepticusInduced_Epileptogenesis_and_Related_Comorbidities

The Pharmacological Inhibition of Fatty Acid Amide Hydrolase Prevents Excitotoxic Damage in the Rat Striatum: Possible Involvement of CB1 Receptors Regulation (link to PDF–2018) https://www.researchgate.net/publication/325369339_The_Pharmacological_Inhibition_of_Fatty_Acid_Amide_Hydrolase_Prevents_

Excitotoxic_Damage_in_the_Rat_Striatum_Possible_Involvement_of_CB1_Receptors_Regulation Oleoylethanolamide and Palmitoylethanolamide Protect Cultured Cortical Neurons Against Hypoxia (link to PDF–2018) https://www.researchgate.net/publication/327784075_Oleoylethanolamide_and_Palmitoylethanolamide_Protect_Cultured_Cortical_Neurons_Against_Hypoxia
Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity (link to PDF–2018) https://www.researchgate.net/publication/324678254_Paraneoplastic_cerebellar_degeneration_Yo_antibody_alters_mitochondrial_calcium_buffering_capacity

Long-term depression induced by endogenous cannabinoids produces neuroprotection via astroglial CB1R after stroke in rodents (click “sagepub” for download–2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Longterm+depression+induced+by+endogenous+cannabinoids+produces+neuroprotection+via+astroglial+CB1R+after+stroke+in+rodents.&btnG=

Cannabis cures the spine (article–2018) https://www.jtcvs.org/article/S0022-5223(18)32080-4/fulltext

Thallium-Induced Toxicity in Rat Brain Crude Synaptosomal/Mitochondrial Fractions is Sensitive to Anti-excitatory and Antioxidant Agents (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29313218

Neuroprotective Effects of MAGL (Monoacylglycerol Lipase) Inhibitors in Experimental Ischemic Stroke (1st page–2018) https://www.deepdyve.com/lp/wolters-kluwer-health/neuroprotective-effects-of-magl-monoacylglycerol-lipase-inhibitors-inGN0Y423b4C?impressionId=5b623c0c1d67d&i_medium=docview&i_campaign=recommendations&i_source=recommendations
Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration:  reversal by cannabidiol (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0361923017303714
The inhibition of CB1 receptor accelerates the onset and development of EAE possibly by regulating microglia/macrophages polarization (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0165572817304678
Chronic cannabidiol exposure promotes functional impairment in sexual behavior and fertility of male mice (abst–2018) https://www.sciencedirect.com/science/article/pii/S0890623818301357?via%3Dihub

Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer’s Disease
(abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29574668
Biphasic Effects of THC in Memory and Cognition (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29574698
Spermidine prevents high glucose-induced senescence in HT-22 cells by upregulation of CB1 receptor (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29699000
β-Caryophyllene (BCP) ameliorates MPP+ induced cytotoxicity (abst–2018)
https://www.sciencedirect.com/science/article/abs/pii/S0753332217370269
Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative
Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset
Alzheimer’s Disease (abst–2018) 
https://link.springer.com/article/10.1007%2Fs40263-018-0515-7
Is Cannabidiol a Promising Substance for New Drug Development? A Review of its
Potential Therapeutic Applications (abst–2018) 
https://www.ncbi.nlm.nih.gov/pubmed/29773016
The biomedical challenge of neurodegenerative disorders: an opportunity for  cannabinoid-based therapies to improve on the poor current therapeutic outcomes  (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29856067
Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29797438
Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors
Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic
Pain (abst–2018) 
https://www.ncbi.nlm.nih.gov/pubmed/29863609
The potential protective effects of cannabinoid receptor agonist WIN55,212-2 on
cognitive dysfunction is associated with the suppression of autophagy and inflammation in an experimental model of vascular dementia (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0165178117314798
Cannabinoids for the treatment of behavioral and psychological symptoms of dementia (abst–2018) https://www.futuremedicine.com/doi/abs/10.2217/nmt-2018-0019?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=nmt

Inhibition of return (IOR) in patients with schizophrenia and cannabis use (abst–2018) https://www.sciencedirect.com/science/article/pii/S0278584618305037?via%3Dihub

Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303198

Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S000629521830337X

Neuroprotective Action of the CB1/2 Receptor Agonist, WIN 55,212-2, against DMSO but Not Phenobarbital-Induced Neurotoxicity in Immature Rats (abst–2018) https://link.springer.com/article/10.1007%2Fs12640-018-9944-9

Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1 channel in an in vitro seizure model (abst–2018) https://www.semanticscholar.org/paper/Inhibitions-of-anandamide-transport-and-FAAH-and-of-Naz%C4%B1ro%C4%9FluTaner/fc43de120f4b6bce503fe59ae74b4f37be7c09e4

Anticonvulsant and Neuroprotective Effects of Cannabidiol During the Juvenile Period (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30169677

Inhibiting a spinal cord signaling pathway protects against ischemia injury in rats (abst–2018) https://www.sciencedirect.com/science/article/pii/S002252231832035X

A systematic review on the neuroprotective perspectives of beta-caryophyllene (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30281175

Avidekel Cannabis extracts and cannabidiol are as efficient as Copaxone in suppressing EAE in SJL/J mice (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30291491Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative (abst–2018) https://www.sciencedirect.com/science/article/pii/S0028390818304830

Marijuana for Parkinson’s Disease? (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450681/

Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554654/

Biological bases for a possible effect of cannabidiol in Parkinson’s disease (full–2019) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462019005012104&lng=en&nrm=iso&tlng=en

Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets (full–2019) https://www.frontiersin.org/articles/10.3389/fnmol.2019.00094/full

Protective Effect of N-Arachidonoyl Glycine-GPR18 Signaling after Excitotoxical Lesion in Murine Organotypic Hippocampal Slice Cultures (full–2019) https://www.mdpi.com/1422-0067/20/6/1266/htm

Cannabis and Cannabinoid Biology in Stroke (1st page–2019) https://www.ahajournals.org/doi/abs/10.1161/STROKEAHA.118.023587

Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30698831

Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain (abst–2019) https://www.sciencedirect.com/science/article/pii/S0960894X19301428?via%3Dihub

Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer’s Disease (abst–2019) https://link.springer.com/article/10.1007%2Fs12035-019-1637-8

Chapter Eight – Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders (abst–2019) https://www.sciencedirect.com/science/article/pii/S0074774219300327?via%3Dihub

Cannabidiol improves vocal learning-dependent recovery from, and reduces magnitude of deficits following, damage to a cortical-like brain region in a songbird pre-clinical animal model (abst–2019) https://www.sciencedirect.com/science/article/pii/S0028390818305343?via%3Dihub

A Cannabinoid Receptor-Mediated Mechanism Participates in the Neuroprotective Effects of Oleamide Against Excitotoxic Damage in Rat Brain Synaptosomes and Cortical Slices (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31286434

Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31396087
Early intervention with electroacupuncture prevents PTSD-like behaviors in rats through enhancing hippocampal endocannabinoid signaling (abst–2019) https://www.sciencedirect.com/science/article/pii/S0278584619300053?via%3Dihub

top


NIEMANN-PICK DISEASE
Endocannabinoids in Caenorhabditis elegans are essential for the mobilization of
cholesterol from internal reserves (full-2018)
https://www.nature.com/articles/s41598-018-24925-8
Chemical Proteomic Analysis of Serine Hydrolase Activity in Niemann-Pick Type C
Mouse Brain (full–2018) https://www.frontiersin.org/articles/10.3389/fnins.2018.00440/full
The endocannabinoid system is affected by cholesterol dyshomeostasis: Insights from a murine model of Niemann Pick type C disease (abst–2019) https://www.sciencedirect.com/science/article/pii/S0969996119301998?via%3Dihub


NIGHTMARES/DREAMS

The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study (summary–2015) https://reachfamilies.umn.edu/research/document/7805 (abst–2015) https://www.sciencedirect.com/science/article/pii/S0306453014004132

Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users (abst–2015) https://www.sciencedirect.com/science/article/abs/pii/S0306460315002269

Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653

The endocannabinoid system modulating levels of consciousness, emotions and likely dream contents. (download – 2017) https://www.researchgate.net/profile/Eric_Murillo-Rodriguez/publication/314102877_The_Endocannabinoid_System_Modulating_Levels_of_Consciousness_Emotions_and_Likely_Dream_Contents/links/595e6633a6fdccc9b17fd7ad/The-Endocannabinoid-System-Modulating-Levels-of-Consciousness-Emotions-and-Likely-Dream-Contents.pdf?origin=publication_detail

Cannabis, Cannabinoids, and Sleep: a Review of the Literature (link to download–2017) https://www.med.upenn.edu/cbti/assets/user-content/documents/s11920-017-0775-9.pdf 

Management of nightmares in patients with posttraumatic stress disorder: current perspectives (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263296/

Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series (full–2018) https://www.liebertpub.com/doi/full/10.1089/acm.2018.0437?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed

Management of Post-Traumatic Nightmares: a Review of Pharmacologic and Nonpharmacologic Treatments Since 2013 (full–2018) https://link.springer.com/article/10.1007%2Fs11920-018-0971-2


NIGHT SWEATS
Dronabinol for the Treatment of Paraneoplastic Night Sweats in Cancer Patients: A Report of Five Cases (full–2019) https://www.liebertpub.com/doi/full/10.1089/jpm.2018.0551?url_ver=Z39.88-2003&rfr_id=ori:rid


NOSE/NASAL PROBLEMS
Endocannabinoid receptor CB2R is significantly expressed in aspirin-exacerbated respiratory disease: a pilot study (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29897665
Impact of habitual marijuana and tobacco smoke on severity of chronic rhinosinusitis (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S0196070919302881?via%3Dihub


NUTRITION-GENERAL*+
Interaction between orexin A and cannabinoid system in the lateral hypothalamus of rats and effects of subchronic intraperitoneal administration of cannabinoid receptor inverse agonist on food intake and the nutritive utilization of protein (full–2015) http://www.jpp.krakow.pl/journal/archive/04_15/pdf/181_04_15_article.pdf
Dietary Carbohydrates that Modulate the Immune System (abst–2015)  http://www.ingentaconnect.com/content/ben/ciemd/2015/00000002/00000001/art00009?crawler=true
Effects of a High-Protein/Low-Carbohydrate versus a Standard Hypocaloric Diet on  Weight and Cardiovascular Risk Factors during 9 Months: Role of a Genetic Variation in  the Cannabinoid Receptor Gene (CNR1) (G1359A Polymorphism) (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25766592
Providing a food reward reduces inhibitory avoidance learning in zebrafish (abst–2015) http://www.sciencedirect.com/science/article/pii/S0376635715300309
Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00208/full
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Long-Term Effects of Prenatal Exposure to Undernutrition on Cannabinoid Receptor Related Behaviors: Sex and Tissue-Specific Alterations in the mRNA Expression of Cannabinoid Receptors and Lipid Metabolic Regulators (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00241/full
Lipids in psychiatric disorders and preventive medicine (full–2016)  http://www.sciencedirect.com/science/article/pii/S0149763415303353
Fabp1 gene ablation inhibits high fat diet-induced increase in brain endocannabinoids (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27861894
Cannabimimetic phytochemicals in the diet – an evolutionary link to food selection and metabolic stress adaptation? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27891602
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis  (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415302943
Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis  Pathophysiology? (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337874/
Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28283967
Precision Nutrition and Omega-3 Polyunsaturated Fatty Acids: A Case for Personalized  Supplementation Approaches for the Prevention and Management of Human Diseases (full–2017) http://www.mdpi.com/2072-6643/9/11/1165/htm
Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and  prebiotics (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655955/
Nutritional status dependent endocannabinoid signalling regulates the integration of rat  visceral information (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451724/
ESSENTIAL DIETARY BIOACTIVE LIPIDS IN NEUROINFLAMMATORY DISEASES (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984567/
Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity (abst–2017) http://www.sciencedirect.com/science/article/pii/S0031938416309817

Analysis of cannabinoids by liquid chromatography–mass spectrometry in milk, liver and hemp seed to ensure food safety (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0308814617301346
Corrigendum to “Analysis of cannabinoids by liquid chromatography-mass spectrometry in milk, liver and hemp seed to ensure food safety” [Food Chem. 228 (2017) 177-185]  https://www.sciencedirect.com/science/article/pii/S0308814618303182?via%3Dihub
Sex-dependent effects of neonatal maternal deprivation on endocannabinoid levels in the adipose tissue: influence of diet (abst–2017)  http://link.springer.com/article/10.1007%2Fs13105-017-0558-0

Metabolic effects of intermittent access to caloric or non-caloric sweetened solutions in mice fed a high-caloric diet (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28347724
Impact of dietary fats on brain functions (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29046155
How four U.S. states are regulating recreational marijuana edibles (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28343113
Perinatal maternal high-fat diet induces early obesity and sex-specific alterations of the  endocannabinoid system in white and brown adipose tissue of weanling rat offspring (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29110748
Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29171003
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics  studies of cannabidiolic acid (CBDA) (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0731708517322367?via%3Dihub
Therapeutic use of Δ9-THC and cannabidiol: evaluation of a new extraction procedure  for the preparation of cannabis-based olive oil (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29189144
Amplification of mGlu5-endocannabinoid signaling rescues behavioral and synaptic  deficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acids  imbalance (abst–2017)  http://www.jneurosci.org/content/early/2017/06/20/JNEUROSCI.3516-16.2017
The presence and distribution of cannabinoid type 1 and 2 receptors in the mandibular  gland: The influence of different physical forms of diets on their expression in piglets (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29218862
Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits  markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29179781
Role of Endocannabinoids on Sweet Taste Perception, Food Preference, and Obesity related Disorders (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29293950
Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes (full–2018) https://www.nature.com/articles/s41387-017-0016-7
Human Milk and Donkey Milk, Compared to Cow Milk, Reduce Inflammatory
Mediators and Modulate Glucose and Lipid Metabolism, Acting on Mitochondrial
Function and Oleylethanolamide Levels in Rat Skeletal Muscle (full–2018)
https://www.frontiersin.org/articles/10.3389/fphys.2018.00032/full

Attenuation of Listeria monocytogenes Virulence by Cannabis sativa L. Essential Oil (full–2018) https://www.frontiersin.org/articles/10.3389/fcimb.2018.00293/full

Impact of maternal western diet-induced obesity on offspring mortality and peripheral endocannabinoid system in mice (full-2018) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0205021

Characterization of an acidic α-galactosidase from hemp (Cannabis sativa L.) seeds and its application in removal of raffinose family oligosaccharides (RFOs) (full-2018) https://ojs.ptbioch.edu.pl/index.php/abp/article/view/1535/1495
Plasma fatty acid ethanolamides are associated with postprandial triglycerides,
ApoCIII and ApoE in humans consuming high fructose corn syrup-sweetened beverage (link to PDF-2018)
https://www.physiology.org/doi/abs/10.1152/ajpendo.00406.2017

Oral Ingestion of Cannabis sativa: Risks, Benefits, and Effects on Malaria-Infected Hosts (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260522/

Production, digestibility and allergenicity of hemp (Cannabis sativa L.) protein isolates (full–2018) https://www.sciencedirect.com/science/article/pii/S0963996918307427?via%3Dihub

Hypothesis: Clues From Mammalian Hibernation for Treating Patients With Anorexia Nervosa (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240652/
Dietary fatty acid composition impacts plasma fatty acid ethanolamide levels and body composition in golden Syrian hamsters (link to PDF–2018) https://www.researchgate.net/publication/325135158_Dietary_fatty_acid_composition_impacts_plasma_fatty_acid_ethanolamide_levels_and_body_composition_in_Golden_Syrian_hamsters

A rapid method to determine nine natural cannabinoids in beverages and food derived from Cannabis sativa by liquid chromatography coupled to tandem mass spectrometry on a QTRAP 4000 (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30030940

Structural equation modeling of food craving across the menstrual cycle using behavioral, neuroendocrine, and metabolic factors (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S003193841830475X

Dietary Galacto-Oligosaccharides and Resistant Starch Protect Against Altered CB1 and 5-HT1A and 2A Receptor Densities in Rat Brain: Implications for Preventing Cognitive and Appetite Dysfunction During a High-Fat Diet (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30152105

Effects of feeding a source of omega-3 fatty acid during the early postpartum period on the endocannabinoid system in the bovine endometrium (abst–2018) https://www.sciencedirect.com/science/article/pii/S0093691X18305880?via%3Dihub

The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial (abst–2018) https://link.springer.com/article/10.1007%2Fs00520-018-4154-9

Effects of polymorphism rs3123554 in the cannabinoid receptor gene type 2 (CB2R) on metabolic and adiposity parameters after weight loss with two hypocaloric diets (abst–2018) http://www.diabetesresearchclinicalpractice.com/article/S0168-8227(18)30143-8/fulltext

Chemical Characterization and Evaluation of the Antibacterial Activity of Essential Oils from Fibre-Type Cannabis sativa L. (Hemp) (full–2019) https://www.mdpi.com/1420-3049/24/12/2302/htm

Countering the Modern Metabolic Disease Rampage With Ancestral Endocannabinoid System Alignment (full-2019) https://www.frontiersin.org/articles/10.3389/fendo.2019.00311/full

Endocannabinoid Metabolome Characterization of Milk from Guatemalan Women Living in the Western Highlands (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517780/

Using Twitter to Understand the Human Bowel Disease Community: Exploratory Analysis of Key Topics (full–2019) https://www.jmir.org/2019/8/e12610/

Omega-3 polyunsaturated fatty acids impinge on CD4+ T cell motility and adipose tissue distribution via direct and lipid mediator-dependent effects (link to PDF–2019) https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz208/5543091

Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31372958Food database of  N-acyl-phosphatidylethanolamines, N-acylethanolamines and endocannabinoids and daily intake from a Western, a Mediterranean and a vegetarian diet (abst–2019) https://www.sciencedirect.com/science/article/pii/S0308814619313263?via%3Dihub

Biological underpinnings from psychosocial stress towards appetite and obesity during youth: research implications towards metagenomics, epigenomics and metabolomics (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31298176

Diet, endocannabinoids, and health (abst–2019) https://www.sciencedirect.com/science/article/pii/S027153171930572X?via%3Dihub

Herring roe oil supplementation alters microglial cell gene expression and reduces peripheral inflammation after immune activation in a neonatal piglet model (abst–2019) https://www.sciencedirect.com/science/article/pii/S0889159119301606?via%3Dihub

The role of n-3 PUFA-derived fatty acid derivatives and their oxygenated metabolites in the modulation of inflammation (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S1098882319300437?via%3Dihub

Salivary endocannabinoids as mediators in the relationship between omega-6 and omega-3 fatty acid ratio intake from highly-processed foods and anthropometric markers of health in women (abst-2019) https://www.tandfonline.com/doi/abs/10.1080/09637486.2019.1632274?journalCode=iijf20

Recreational Marijuana Laws and Junk Food Consumption: Evidence Using Border Analysis and Retail Sales Data (abst–2019) https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3328613

Maternal coconut oil intake on lactation programs for endocannabinoid system dysfunction in adult offspring (abst–2019) https://www.sciencedirect.com/science/article/pii/S0278691519302637?via%3Dihub

Metabolic syndrome and osteoarthritis pain: common molecular mechanisms and potential therapeutic implications (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31408694

The effects of storage conditions on long-chain polyunsaturated fatty acids, lipid mediators, and antioxidants in donor human milk – A review (abst–2019) https://www.plefa.com/article/S0952-3278(19)30043-2/fulltext


NUTRITION-HEMP SEED*+
Characterization of Lignanamides from Hemp (Cannabis sativa L.) Seed and their Antioxidant and Acetylcholinesterase Inhibitory Activities (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26585089
Alteration of delta-6-desaturase (FADS2), secretory phospholipase-A2 (sPLA2) enzymes by Hot-nature diet with co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26365444
Effect of Hempseed (Cannabis sativa sp.) Inclusion to the Diet on Performance, Carcass and Antioxidative Activity in Japanese Quail (Coturnix coturnix japonica) (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597843/
Variability in Seed Traits in a Collection of Cannabis sativa L. Genotypes (full-2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00688/full
Effects of Different Levels of Hemp Seed (Cannabis Sativa L.) and Dextran Oligosaccharide on Growth Performance and Antibody Titer Response of Broiler Chickens (full–2016) http://www.tandfonline.com/doi/full/10.4081/ijas.2015.3473
Proteomic characterization of hempseed (Cannabis sativa L.) (abst–2016) http://www.sciencedirect.com/science/article/pii/S1874391916302354
Seed composition of ten industrial hemp cultivars approved for production in Canada (abst–2016) http://www.sciencedirect.com/science/article/pii/S088915751400194X
Determination of cannabinoids in hemp nuts products in Taiwan by HPLC-MS/MS coupled with chemometric analysis: Quality evaluation and a pilot human study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27590030
Standardized Cannabis sativa extract attenuates tau and stathmin gene expression in the melanoma cell line (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673704/
Extract of Fructus Cannabis Ameliorates Learning and Memory Impairment Induced by  D-Galactose in an Aging Rats Model (full–2017)  https://www.hindawi.com/journals/ecam/2017/4757520/
Hemp Industries Association, et al., Petitioners ) v. Drug Enforcement Administration, et  al., Respondents (download–2017)  https://thehia.org/resources/Documents/Legal/HIA-v-DEA-9th-Circuit-Motion.pdf
Textual research on Han-Chinese formulae collected in Tubo medical manuscript  unearthed in ‘Bum-pa-Che Tower (abst in English–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28103984 (abst in Chinese) http://zhyszz.yiigle.com/CN112155201606/942250.htm?locale=zh_CN
Analysis of cannabinoids by liquid chromatography–mass spectrometry in milk, liver and hemp seed to ensure food safety (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0308814617301346
Corrigendum to “Analysis of cannabinoids by liquid chromatography-mass spectrometry in milk, liver and hemp seed to ensure food safety” [Food Chem. 228 (2017) 177-185]  https://www.sciencedirect.com/science/article/pii/S0308814618303182?via%3Dihub
Effect of dietary supplementation of hemp seed (Cannabis sativa L.) on meat quality and  egg fatty acid composition of Japanese quail (Coturnix coturnix japonica) (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28444789

Exploration of Potentially Bioactive Peptides Generated from the Enzymatic Hydrolysis  of Hempseed Proteins (abst–2017)  http://pubs.acs.org/doi/10.1021/acs.jafc.7b03590
New ACE-Inhibitory Peptides from Hemp Seed (Cannabis sativa L.) Proteins (abst–2017) http://pubs.acs.org/doi/10.1021/acs.jafc.7b04522
(±)-Sativamides A and B, Two Pairs of Racemic Nor-Lignanamide Enantiomers from the  Fruits of Cannabis sativa (abst–2017)  https://pubs.acs.org/doi/10.1021/acs.joc.7b02765
Uncovering the Mechanisms of Chinese Herbal Medicine (MaZiRenWan) for Functional Constipation by Focused Network Pharmacology Approach (full–2018)
https://www.frontiersin.org/articles/10.3389/fphar.2018.00270/full
Nutritional Value of Commercial Protein-Rich Plant Products (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956054/

Characterization of an acidic α-galactosidase from hemp (Cannabis sativa L.) seeds and its application in removal of raffinose family oligosaccharides (RFOs) (full–2018) https://ojs.ptbioch.edu.pl/index.php/abp/article/view/1535/1495

Hemp (Cannabis sativa L.) Seed Phenylpropionamides Composition and Effects on Memory Dysfunction and Biomarkers of Neuroinflammation Induced by Lipopolysaccharide in Mice (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288804/

Comparative Study of Chemical, Biochemical Characteristic and ATR-FTIR Analysis of Seeds, Oil and Flour of the Edible Fedora Cultivar Hemp (Cannabis sativa L.) (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337080/

Hemp (Marijuana) reverted Copper-induced toxic effects on the essential fatty acid profile of Labeo rohita and Cirrhinus mrigala. (link to PDF–2018) https://www.researchgate.net/publication/328957738_Hemp_Marijuana_reverted_Copperinduced_toxic_effects_on_the_essential_fatty_acid_profile_of_Labeo_rohita_and_Cirrhinus_mrigala

Pro-technological and functional characterization of lactic acid bacteria to be used as starters for hemp (Cannabis sativa L.) sourdough fermentation and wheat bread fortification (link to PDF–2018) https://www.researchgate.net/publication/324738654_Protechnological_and_functional_characterization_of_lactic_acid_bacteria_to_be_used_as_starters_for_hemp_Cannabis_sativa_L_sourdough_fermentation_and_wheat_bread_fortification


Nutraceutical potential of hemp (Cannabis sativa L.) seeds and sprouts (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0308814618307180?via%3Dihub

(±)-Sativamides A and B, Two Pairs of Racemic Nor-Lignanamide Enantiomers from the Fruits of Cannabis sativa (abst–2018) https://pubs.acs.org/doi/10.1021/acs.joc.7b02765
A rapid method to determine nine natural cannabinoids in beverages and food derived from Cannabis sativa by liquid chromatography coupled to tandem mass spectrometry on a QTRAP 4000 (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30030940

Effects of Heat-Treated Hempseed Supplementation on Performance, Egg Quality, Sensory Evaluation and Antioxidant Activity of Laying Hens (abst–2018) https://www.tandfonline.com/doi/abs/10.1080/00071668.2018.1547360?journalCode=cbps20

Cannabisin F from Hemp (Cannabis sativa) Seed Suppresses Lipopolysaccharide-Induced Inflammatory Responses in BV2 Microglia as SIRT1 Modulator (full–2019) https://www.mdpi.com/1422-0067/20/3/507/htm

Effect of dietary supplementation of hemp (Cannabis sativa) and dill seed (Anethum graveolens) on performance, serum biochemicals and gut health of broiler chickens (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30604902

Use of natural ingredients in the Japanese quail diet and their effect on carcass and meat quality. Review (link to PDF–2019) https://www.ajas.info/journal/view.php?doi=10.5713/ajas.18.0800
top


NUTRITION-HEMP SEED OIL*+
Effect of ultrasound pre-treatment of hemp (Cannabis sativa L.) seed on super-critical CO2 extraction of oil (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348290/ 
Stability of cosmetic emulsion containing different amount of hemp oil (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25704610
Effect-directed analysis of cold-pressed hemp, flax and canola seed oils by planar chromatography linked with (bio)assays and mass spectrometry (abst–2015) http://www.sciencedirect.com/science/article/pii/S0308814615005890
top
Variability in Seed Traits in a Collection of Cannabis sativa L. Genotypes (full-2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00688/full

Polyphenolic Compounds and Antioxidant Activity of Cold-Pressed Seed Oil from Finola Cultivar of Cannabis sativa L. (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27076277
Cannabinoid Poisoning by Hemp Seed Oil in a Child (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27299295
Formulation, Characterization and Properties of Hemp Seed Oil and Its Emulsions  (full–2017) http://www.mdpi.com/1420-3049/22/5/700/htm
Accelerated Burn Wound Closure in Mice with a New Formula Based on Traditional  Medicine (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292211/
Challenges towards Revitalizing Hemp: A Multifaceted Crop (full–2017)  http://www.cell.com/trends/plant-science/fulltext/S1360-1385(17)30177-2
Hemp Industries Association, et al., Petitioners ) v. Drug Enforcement Administration et  al., Respondents (download–2017)  https://thehia.org/resources/Documents/Legal/HIA-v-DEA-9th-Circuit-Motion.pdf
Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome  after Human Papillomavirus Vaccination (link to PDF–2017)  https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4042
Effect of unconventional oilseeds (safflower, poppy, hemp, camelina) on in vitro ruminal  methane production and fermentation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28188639
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics  studies of cannabidiolic acid (CBDA) (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0731708517322367?via%3Dihub

(link to PDF–2018) https://www.researchgate.net/publication/324738654_Protechnological_and_functional_characterization_of_lactic_acid_bacteria_to_be_used_as_starters_for_hemp_Cannabis_sativa_L_sourdough_fermentation_and_wheat_bread_fortification

Hemp Industries Association, et al., Petitioners ) v. Drug Enforcement Administration, et al., Respondents (download–2017) https://thehia.org/resources/Documents/Legal/HIA-v-DEA-9th-Circuit-Motion.pdf

Effect of cannabis oil on growth performance, haematology and metabolism of Nile Tilapia Oreochromis niloticus (1st page/abst–2017) https://www.deepdyve.com/lp/wiley/effect-of-cannabis-oil-on-growth-performance-haematology-and-C0b9A4KRra https://www.was.org/meetings/ShowAbstract.aspx?Id=47936

Effect of unconventional oilseeds (safflower, poppy, hemp, camelina) on in vitro ruminal methane production and fermentation (abst–2017) https://www.semanticscholar.org/paper/Effect-of-unconventional-oilseeds-(safflower%2C-hemp%2C-WangKreuzer/2fb049a5043c55f906bbf581377d5464eb68b3db

Comparative Study of Chemical, Biochemical Characteristic and ATR-FTIR Analysis of Seeds, Oil and Flour of the Edible Fedora Cultivar Hemp (Cannabis sativa L.) (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337080/


A rapid method to determine nine natural cannabinoids in beverages and food derived from Cannabis sativa by liquid chromatography coupled to tandem mass spectrometry on a QTRAP 4000 (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/30030940


NUTRITION-HEMP SEED PROTEIN ISOLATES/POWDERS
Denaturation and Oxidative Stability of Hemp Seed (Cannabis sativa L.) Protein Isolate as Affected by Heat Treatment (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26142888
Hemp Industries Association, et al., Petitioners ) v. Drug Enforcement Administration et  al., Respondents (download–2017)  https://thehia.org/resources/Documents/Legal/HIA-v-DEA-9th-Circuit-Motion.pdf
New ACE-Inhibitory Peptides from Hemp Seed (Cannabis sativa L.) Proteins (abst–2017) http://pubs.acs.org/doi/10.1021/acs.jafc.7b04522

Comparative Study of Chemical, Biochemical Characteristic and ATR-FTIR Analysis of Seeds, Oil and Flour of the Edible Fedora Cultivar Hemp (Cannabis sativa L.) (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337080/

Production, digestibility and allergenicity of hemp (Cannabis sativa L.) protein isolates (full–2018) https://www.sciencedirect.com/science/article/pii/S0963996918307427?via%3Dihub
top


NUTRITION-HIGH FAT DIET and the ENDOCANNABINOID SYSTEM
Effects of co-administration of 2-arachidonylglycerol (2-AG) and a selective µ-opioid  receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat  (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522234/
Fatty acid binding protein 5 (FABP5) regulates diet-induced obesity (DIO) via GIP  secretion from enteroendocrine K-cells in response to fat ingestion (full–2015)  http://ajpendo.physiology.org/content/308/7/E583.long
Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with diet induced obesity (full–2015)  http://onlinelibrary.wiley.com/enhanced/doi/10.1111/bph.13056
Fat Diet-Induced Insulin Resistance Does Not Increase Plasma Anandamide Levels or Potentiate Anandamide Insulinotropic Effect in Isolated Canine Islets (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0123558
CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via  upregulation of liver adiponectin receptors (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609878/
Orexin-A and Endocannabinoid Activation of the Descending Antinociceptive Pathway  Underlies Altered Pain Perception in Leptin Signalling Deficiency (full–2015)  http://www.nature.com/npp/journal/v41/n2/full/npp2015173a.html
Intermittent access to liquid sucrose differentially modulates energy intake and related central pathways in control or high-fat fed mice (abst–2015)
https://www.sciencedirect.com/science/article/abs/pii/S0031938414006106
Cannabinoid 2 Receptor Agonist Improves Systemic Sensitivity to Insulin in High-Fat  Diet/Streptozotocin-Induced Diabetic Mice (full–2016)  https://www.karger.com/Article/FullText/453171

Early Low Fat Diet Enriched with Linolenic Acid Reduces Liver Endocannabinoid Tone  and Improves Late Glycemic Control After a High Fat Diet Challenge in Mice  (full–2016) http://diabetes.diabetesjournals.org/content/65/7/1824.long
A role for the endocannabinoid 2-arachidonoyl-sn-glycerol for social and high-fat food  reward in male mice (full–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26873082
Fabp1 gene ablation inhibits high fat diet-induced increase in brain endocannabinoids (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225076/
Cannabinoid-glutamate interactions in the regulation of food intake in neonatal layer type chicks: role of glutamate NMDA and AMPA receptors (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27000110

Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat  diet-induced obesity (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26880264
Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by  increasing forkhead box O1 activity in a mouse model of obesity (abst–2016)  http://www.spandidos-publications.com/10.3892/ijmm.2016.2475
Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28283967
Rimonabant improves metabolic parameters partially attributed to restoration of high  voltage-activated Ca2+ channels in skeletal muscle in HFD-fed mice (full–2017)  http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000600602&lng=en&nrm=iso&tlng=en (full–in varous languages)  http://www.scielo.br/scieloOrg/php/translate.php?pid=S0100-879X2017000600602&caller=www.scielo.br&lang=en&tlang=en&script=sci_arttext
Simvastatin and Bezafibrate ameliorate Emotional disorder Induced by High fat diet in  C57BL/6 mice (full-2017)  https://www.nature.com/articles/s41598-017-02576-5
Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis  Pathophysiology? (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337874/
Review: The Role of Cannabinoids on Esophageal Function—What We Know Thus Far (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665514/
Precision Nutrition and Omega-3 Polyunsaturated Fatty Acids: A Case for Personalized Supplementation Approaches for the Prevention and Management of Human Diseases  (full–2017) http://www.mdpi.com/2072-6643/9/11/1165/htm
Obesity is a concern for bone health with aging (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385856/
Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response  to a high fat diet. (click “Full Text” for download–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28972119

The rewarding effects of ethanol are modulated by binge eating of a high-fat diet during  adolescence (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301909
Oral haloperidol or olanzapine intake produces distinct and region-specific increase in  cannabinoid receptor levels that is prevented by high fat diet (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28619471
Impact of dietary fat on gut microbiota and low-grade systemic inflammation:  mechanisms and clinical implications on obesity (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/09637486.2017.1343286?journalCode=iijf20
Impact of dietary fats on brain functions (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/29046155
Maternal high-fat diet induces sex-specific endocannabinoid system changes in newborn rats and programs adiposity, energy expenditure and food preference in adulthood (abst–2017) http://www.sciencedirect.com/science/article/pii/S0955286317303042?via%3Dihub
Perinatal maternal high-fat diet induces early obesity and sex-specific alterations of the  endocannabinoid system in white and brown adipose tissue of weanling rat offspring  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29110748
EFFECT OF MATERNAL HIGH-FAT DIET ON KEY COMPONENTS OF THE PLACENTAL AND HEPATIC ENDOCANNABINOID SYSTEM (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29138223
Metabolic effects of intermittent access to caloric or non-caloric sweetened solutions in  mice fed a high-caloric diet (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28347724
Effects of acute exposure to chlorpyrifos on cholinergic and non-cholinergic targets in  normal and high-fat fed male C57BL/6J mice (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0041008X17304295?via%3Dihub
Short-term high-fat diet primes excitatory synapses for long-term depression in orexin  neurons (abst–2017)  http://onlinelibrary.wiley.com/doi/10.1113/JP275177/abstract
Protective Effects of Gomisin N against Hepatic Cannabinoid Type 1 Receptor-Induced Insulin Resistance and Gluconeogenesis (full–2018)  http://www.mdpi.com/1422-0067/19/4/968
Endocannabinoids in Body Weight Control (full–2018) http://www.mdpi.com/1424-8247/11/2/55/htm
Limited Access to a High Fat Diet Alters Endocannabinoid Tone in Female Rats (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801427/
Absence of cannabinoid 1 receptor in beta cells protects against high-fat/high-sugar diet induced beta cell dysfunction and inflammation in murine islets (full–2018)
https://link.springer.com/article/10.1007%2Fs00125-018-4576-4

Orosensory Detection of Dietary Fatty Acids Is Altered in CB1R−/− Mice (full–2018) https://www.mdpi.com/2072-6643/10/10/1347/htm

Endocannabinoid Signaling at Hypothalamic Steroidogenic Factor-

1/Proopiomelanocortin Synapses Is Sex- and Diet-Sensitive (full–2018) https://www.frontiersin.org/articles/10.3389/fnmol.2018.00214/full

Maternal high-fat diet consumption induces sex-dependent alterations of the endocannabinoid system and redox homeostasis in liver of adult rat offspring (full–2018) https://www.nature.com/articles/s41598-018-32906-0

Impact of maternal western diet-induced obesity on offspring mortality and peripheral endocannabinoid system in mice (full-2018) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0205021

Effects of high-fat diet and age on the blood lipidome and circulating endocannabinoids of female C57BL/6 mice (full–2018) https://www.sciencedirect.com/science/article/pii/S1388198117302044?via%25

Role of cannabinoid receptor type 1 in rostral ventrolateral medulla in high-fat dietinduced hypertension in rats (link to PDF–2018) https://www.researchgate.net/publication/322671883_Role_of_cannabinoid_receptor_type_1_in_rostral_ventrolateral_medulla_in_high-fat_diet-induced_hypertension_in_rats
Endocannabinoids in Islets of Langerhans: The Ugly, the Bad and the Good Facts (link to PDF–2018) https://www.researchgate.net/publication/324269454_Endocannabinoids_in_Islets_of_Langerhans_The_Ugly_the_Bad_and_the_Good_Facts
Salivary endocannabinoids and N-acylethanolamines upon mastication of a semisolid food: implications in fat taste, appetite and food liking (abst–2018) http://pubs.rsc.org/en/Content/ArticleLanding/2018/FO/C7FO01772C#!divAbstract

Scp-2/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0003986118300377?via%3Dihub
Inhibition of cholinergic and non-cholinergic targets following subacute exposure to
chlorpyrifos in normal and high fat fed male C57BL/6J mice (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0278691518304253
Role for fatty acid amide hydrolase (FAAH) in the leptin-mediated effects on feeding and energy balance (abst–2018)  http://www.pnas.org/content/early/2018/06/27/1802251115.long
Structural equation modeling of food craving across the menstrual cycle using behavioral, neuroendocrine, and metabolic factors (abst–2018)
https://www.sciencedirect.com/science/article/abs/pii/S003193841830475X

Structural equation modeling of food craving across the menstrual cycle using behavioral, neuroendocrine, and metabolic factors (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S003193841830475X

Dietary Galacto-Oligosaccharides and Resistant Starch Protect Against Altered CB1 and 5-HT1A and 2A Receptor Densities in Rat Brain: Implications for Preventing Cognitive and Appetite Dysfunction During a High-Fat Diet (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30152105

Monoacylglycerol lipase deficiency affects diet-induced obesity, fat absorption, and feeding behavior in CB1 cannabinoid receptor-deficient mice (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30265576

Preclinical and Clinical Evidence for a Distinct Regulation of Mu Opioid and Type 1 Cannabinoid Receptor Genes Expression in Obesity (full–2019) https://www.frontiersin.org/articles/10.3389/fgene.2019.00523/full

Countering the Modern Metabolic Disease Rampage With Ancestral Endocannabinoid System Alignment (full–2019) https://www.frontiersin.org/articles/10.3389/fendo.2019.00311/full

Hypothalamic endocannabinoids inversely correlate with the development of diet induced obesity in male and female mice (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602126/

Joint and separate exposure to alcohol and ∆9-tetrahydrocannabinol produced distinct effects on glucose and insulin homeostasis in male rats (full–2019) https://www.nature.com/articles/s41598-019-48466-w

Diet-Induced Obesity in Cannabinoid-2 Receptor Knockout Mice and Cannabinoid Receptor 1/2 Double-Knockout Mice (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30699233

Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high-fat high cholesterol diet via regulating NF-κB and NLRP3 inflammasome pathway (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31032942

Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy (important) (abst–2019)https://onlinelibrary.wiley.com/doi/abs/10.1111/epi.16093

Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31372958

Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system (abst–2019) https://www.clinicalnutritionjournal.com/article/S0261-5614(19)30231-6/fulltext

Maternal coconut oil intake on lactation programs for endocannabinoid system dysfunction in adult offspring (abst–2019) https://www.sciencedirect.com/science/article/pii/S0278691519302637?via%3Dihub

The TRPV1 channel regulates glucose metabolism (abst–2019) https://www.physiology.org/doi/abs/10.1152/ajpendo.00102.2019

Maternal high-fat diet impairs leptin signaling and up-regulates type-1 cannabinoid receptor with sex-specific epigenetic changes in the hypothalamus of newborn rats (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S0306453018308412?via%3Dihub
top


Updated 4 October, 2019